Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Ischemic Heart Disease

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 454 articles:
HTML format



Single Articles


    October 2024
  1. HUANG J, He Q, Jiang Y, Wong JMJ, et al
    Low ambient temperature and incident myocardial infarction with or without obstructive coronary arteries: a Chinese nationwide study.
    Eur Heart J. 2024 Oct 28:ehae711. doi: 10.1093.
    PubMed     Abstract available


  2. CHARTON J, Bouteiller X, Gandjbakhch E, Waintraub X, et al
    Overdrive pacing for ventricular fibrillation storm after myocardial infarction.
    Eur Heart J. 2024 Oct 18:ehae698. doi: 10.1093.
    PubMed    


  3. LIUZZO G, Patrono C
    Weekly Journal Scan: Do older patients with non-ST-segment elevation myocardial infarction receive any benefit from a routine invasive strategy?
    Eur Heart J. 2024 Oct 18:ehae684. doi: 10.1093.
    PubMed    


  4. RAJAKULASINGAM R, Ferreira PF, Scott AD, Khalique Z, et al
    Characterization of dynamic changes in cardiac microstructure after reperfused ST-elevation myocardial infarction by biphasic diffusion tensor cardiovascular magnetic resonance.
    Eur Heart J. 2024 Oct 15:ehae667. doi: 10.1093.
    PubMed     Abstract available


  5. CREA F
    Focus on ischaemic heart disease: secondary prevention, cardiogenic shock, and novel therapeutic targets.
    Eur Heart J. 2024;45:4141-4144.
    PubMed    


  6. TITOVA OE, Yuan S, Byberg L, Baron JA, et al
    Plasma proteome and incident myocardial infarction: sex-specific differences.
    Eur Heart J. 2024 Oct 14:ehae658. doi: 10.1093.
    PubMed     Abstract available


  7. BARTON AK, Lau ES, Gulati M
    Steps towards curing Yentl syndrome: appraising sex differences in circulating proteins and incident myocardial infarction.
    Eur Heart J. 2024 Oct 14:ehae657. doi: 10.1093.
    PubMed    


  8. DESCH S, Zeymer U, Akin I, Behnes M, et al
    Routine extracorporeal life support in infarct-related cardiogenic shock: 1-year results of the ECLS-SHOCK trial.
    Eur Heart J. 2024;45:4200-4203.
    PubMed    


  9. WEINTRAUB WS, Boden WE
    Achieving successful prevention of coronary artery disease: a worldwide call to action.
    Eur Heart J. 2024;45:4197-4199.
    PubMed    


  10. LUSEBRINK E, Binzenhofer L, Thiele H
    The DanGer Shock trial: a new dawn but much to uncover.
    Eur Heart J. 2024;45:4181-4183.
    PubMed    


  11. LUSCHER TF, Thiele H
    Cardiogenic shock: do we need a paradigm shift?
    Eur Heart J. 2024;45:4178-4180.
    PubMed    



  12. Correction to: Great debate: myocardial infarction after cardiac surgery must be redefined.
    Eur Heart J. 2024 Oct 11:ehae734. doi: 10.1093.
    PubMed    


  13. AJUFO EC, Tedrow UB
    Refining the stratification of sudden cardiac death risk after myocardial infarction-beyond ejection fraction.
    Eur Heart J. 2024 Oct 8:ehae272. doi: 10.1093.
    PubMed    


  14. PEEK N, Hindricks G, Akbarov A, Tijssen JGP, et al
    Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts.
    Eur Heart J. 2024 Oct 8:ehae326. doi: 10.1093.
    PubMed     Abstract available


  15. SHIMADA T, Fujisawa N, Otsuka K
    Intracoronary polarimetric signatures of exercise-induced vasospastic angina.
    Eur Heart J. 2024;45:3894.
    PubMed    


    September 2024
  16. CREA F
    New Guidelines and a focus on ischaemic heart disease, atrial fibrillation, innovative treatments of channelopathies.
    Eur Heart J. 2024;45:3299-3302.
    PubMed    


  17. BAIREY MERZ CN
    Vulnerable plaque and major adverse cardiovascular events: anatomy of a failure.
    Eur Heart J. 2024;45:3748-3750.
    PubMed    


  18. BODEN WE, De Caterina R, Kaski JC, Bairey Merz N, et al
    Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving international clinical practice guidelines.
    Eur Heart J. 2024;45:3701-3706.
    PubMed     Abstract available


  19. VRINTS C, Andreotti F, Koskinas KC, Rossello X, et al
    2024 ESC Guidelines for the management of chronic coronary syndromes.
    Eur Heart J. 2024;45:3415-3537.
    PubMed    


  20. NURMOHAMED NS, Min JK, Anthopolos R, Reynolds HR, et al
    Atherosclerosis quantification and cardiovascular risk: the ISCHEMIA trial.
    Eur Heart J. 2024;45:3735-3747.
    PubMed     Abstract available


  21. VERGALLO R, Liuzzo G
    Weekly Journal Scan: The prognostic value of coronary inflammation in patients with non-obstructive coronary artery disease.
    Eur Heart J. 2024;45:3311-3313.
    PubMed    


  22. PEDICINO D, Volpe M
    Weekly Journal Scan: increased incidence of acute myocardial infarction in patients with laboratory-confirmed influenza infection.
    Eur Heart J. 2024 Sep 25:ehae569. doi: 10.1093.
    PubMed    


  23. GAUDINO M, Jaffe AS, Milojevic M, Sandoval Y, et al
    Great debate: myocardial infarction after cardiac surgery must be redefined.
    Eur Heart J. 2024 Sep 16:ehae416. doi: 10.1093.
    PubMed    


  24. BADIMON L, Kiss A, Podesser BK
    Spleen in action for cardioprotection.
    Eur Heart J. 2024;45:3178-3180.
    PubMed    


  25. NISHI T, Kume T, Saito Y, Kato K, et al
    Intraplaque haemorrhage, coronary spasm, and resuscitated cardiac arrest in patients with non-obstructive coronary artery disease.
    Eur Heart J. 2024;45:3181-3183.
    PubMed    


  26. LIUZZO G, Patrono C
    Weekly Journal Scan: a penULTIMATE frontier for optimal antiplatelet therapy after drug-eluting stenting in acute coronary syndromes?
    Eur Heart J. 2024;45:3108-3110.
    PubMed    


  27. LIEDER HR, Paket U, Skyschally A, Rink AD, et al
    Vago-splenic signal transduction of cardioprotection in humans.
    Eur Heart J. 2024;45:3164-3177.
    PubMed     Abstract available


  28. GIBSON CM, Duffy D, Bahit MC, Chi G, et al
    Apolipoprotein A-I Infusions and Cardiovascular Outcomes in Acute Myocardial Infarction According to Baseline LDL-Cholesterol Levels: The AEGIS-II Trial.
    Eur Heart J. 2024 Sep 2:ehae614. doi: 10.1093.
    PubMed     Abstract available


  29. TANIWAKI M, Haner JD, Kakizaki R, Ohno Y, et al
    Long-term effect of biodegradable vs durable polymer everolimus-eluting stents on neoatherosclerosis in ST-segment elevation myocardial infarction: the CONNECT trial.
    Eur Heart J. 2024 Sep 1:ehae589. doi: 10.1093.
    PubMed     Abstract available


  30. EITEL I, Saraei R, Jurczyk D, Fach A, et al
    Glycoprotein IIb/IIIa Inhibitors in Acute Myocardial Infarction and Angiographic Microvascular Obstruction: The REVERSE-FLOW Trial.
    Eur Heart J. 2024 Sep 1:ehae587. doi: 10.1093.
    PubMed     Abstract available


  31. SCHUBERT J, Leosdottir M, Lindahl B, Westerberg J, et al
    Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry.
    Eur Heart J. 2024 Sep 1:ehae576. doi: 10.1093.
    PubMed     Abstract available


  32. VAN DEN BROEK WWA, Ten Berg JM
    The puzzle of antiplatelet therapy in ACS: ticagrelor monotherapy is another missing piece.
    Eur Heart J. 2024;45:3057-3059.
    PubMed    


  33. PRENDERGAST BD, Patterson T, Redwood S
    Acute coronary occlusion during valve-in-valve TAVI-a shortcut to successful prevention.
    Eur Heart J. 2024;45:3042-3044.
    PubMed    


    August 2024
  34. ONDRACEK AS, Afonyushkin T, Aszlan A, Taqi S, et al
    Malondialdehyde-specific natural IgM inhibit NETosis triggered by culprit site-derived extracellular vesicles from myocardial infarction patients.
    Eur Heart J. 2024 Aug 31:ehae584. doi: 10.1093.
    PubMed    


  35. GERHARDT T, Landmesser U
    Malondialdehyde-specific natural IgM inhibit NETosis triggered by coronary extracellular vesicles of myocardial infarction patients.
    Eur Heart J. 2024 Aug 31:ehae554. doi: 10.1093.
    PubMed    



  36. Correction to: Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score.
    Eur Heart J. 2024 Aug 30:ehae581. doi: 10.1093.
    PubMed    


  37. MCEVOY JW, Jennings C, Kotseva K, De Bacquer D, et al
    Variation in Secondary Prevention of Coronary Heart Disease: The INTERASPIRE Study.
    Eur Heart J. 2024 Aug 30:ehae558. doi: 10.1093.
    PubMed     Abstract available


  38. TARDIF JC, Ouellette K, Boulet J
    Colchicine improves outcomes in coronary disease, but will it in heart failure?
    Eur Heart J. 2024 Aug 30:ehae612. doi: 10.1093.
    PubMed    


  39. CREA F
    Expanding knowledge in atrial fibrillation, blood pressure treatment, and management of coronary and peripheral artery disease.
    Eur Heart J. 2024;45:2795-2799.
    PubMed    


  40. PAVASINI R, Biscaglia S, Kunadian V, Hakeem A, et al
    Coronary artery disease management in older adults: revascularization and exercise training.
    Eur Heart J. 2024;45:2811-2823.
    PubMed     Abstract available


  41. CREA F
    Heart failure and ischaemic heart disease: new challenges and opportunities.
    Eur Heart J. 2024;45:2681-2685.
    PubMed    


  42. BURZOTTA F, Zito A, Aurigemma C, Romagnoli E, et al
    Fractional flow reserve or optical coherence tomography for angiographically intermediate coronary stenoses: 5-year outcomes in the FORZA trial.
    Eur Heart J. 2024;45:2785-2788.
    PubMed    


  43. VOLLEBERG R, Damman P, van Royen N
    Dissection-like appearance of focal catheter-induced vasospasm in intracoronary optical coherence tomography.
    Eur Heart J. 2024;45:2793.
    PubMed    


  44. CIULLO A, Li L, Li C, Tsi K, et al
    Non-coding RNA yREX3 from human extracellular vesicles exerts macrophage-mediated cardioprotection via a novel gene-methylating mechanism.
    Eur Heart J. 2024;45:2660-2673.
    PubMed     Abstract available


  45. PEDICINO D, Vergallo R
    Weekly Journal Scan: Drug-coated balloon for the treatment of in-stent restenosis - the AGENT IDE trial.
    Eur Heart J. 2024;45:2592-2593.
    PubMed    


    July 2024
  46. LIUZZO G, Patrono C
    Weekly Journal Scan: apolipoprotein A1 is not an adequate shield against early vascular events after acute myocardial infarction.
    Eur Heart J. 2024 Jul 26:ehae446. doi: 10.1093.
    PubMed    


  47. BESOLA L, Colli A, De Caterina R
    Coronary bypass surgery for multivessel disease after percutaneous coronary intervention in acute coronary syndromes: why, for whom, how early?
    Eur Heart J. 2024 Jul 26:ehae413. doi: 10.1093.
    PubMed     Abstract available


  48. KANG J, Yun J, Park KW, Park M, et al
    Long-term outcomes of high bleeding risk patients undergoing percutaneous coronary intervention: a Korean nationwide registry.
    Eur Heart J. 2024 Jul 23:ehae462. doi: 10.1093.
    PubMed     Abstract available


  49. CREA F
    Focus on acute myocardial infarction, sex-related differences in coronary bypass surgery, inflammation in heart failure, and infective endocarditis in prosthetic valves.
    Eur Heart J. 2024;45:2463-2467.
    PubMed    


  50. GIANNITSIS E, Frey N, Katus HA
    Accelerated high sensitivity troponin diagnostics: ready for an even faster pace?
    Eur Heart J. 2024;45:2516-2518.
    PubMed    


  51. DIEZ BENAVENTE E, Sakkers TR, van der Harst P, den Ruijter HM, et al
    Atherosclerotic plaque-specific methylation biomarkers in plasma cell-free DNA of female and male patients with coronary artery disease.
    Eur Heart J. 2024;45:2468-2470.
    PubMed    


  52. AHMAD Y, Lansky AJ
    Periprocedural myocardial infarction: thresholds of (in)significance.
    Eur Heart J. 2024 Jul 19:ehae451. doi: 10.1093.
    PubMed    


  53. JURADO-ROMAN A, Agudo-Quilez P
    Tailoring antithrombotic treatment in patients with acute myocardial infarction and cancer: virtue lies in balance.
    Eur Heart J. 2024 Jul 19:ehae445. doi: 10.1093.
    PubMed    


  54. DAFAALLA M, Costa F, Kontopantelis E, Araya M, et al
    Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score.
    Eur Heart J. 2024 Jul 17:ehae463. doi: 10.1093.
    PubMed     Abstract available


  55. FIGTREE GA, Gray MP
    Improving clinical outcomes for patients with coronary artery disease despite no standard modifiable cardiovascular risk factors (SMuRF): not out of the woods yet.
    Eur Heart J. 2024;45:2407-2409.
    PubMed    


  56. ROGER G, Ducrocq G, Mesnier J, Sayah N, et al
    Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry.
    Eur Heart J. 2024;45:2396-2406.
    PubMed     Abstract available


  57. BEKKI M, Tahara N, Fukumoto Y
    Primary cardiac lymphoma causing coronary artery compression and massive tricuspid regurgitation.
    Eur Heart J. 2024 Jul 2:ehae390. doi: 10.1093.
    PubMed    


    June 2024
  58. SCHELDEMAN L, Sinnaeve P, Albers GW, Lemmens R, et al
    Acute myocardial infarction and ischaemic stroke: differences and similarities in reperfusion therapies-a review.
    Eur Heart J. 2024 Jun 28:ehae371. doi: 10.1093.
    PubMed     Abstract available


  59. VILAHUR G, Radike M, Badimon L
    Novel cardioprotective approaches in ischaemic heart disease.
    Eur Heart J. 2024;45:2109-2111.
    PubMed    


  60. HOLFELD J, Nagele F, Polzl L, Engler C, et al
    Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial.
    Eur Heart J. 2024 Jun 20:ehae341. doi: 10.1093.
    PubMed     Abstract available


  61. SCHLOTTER F, Huber K, Hassager C, Halvorsen S, et al
    Ventricular septal defect complicating acute myocardial infarction: diagnosis and management. A Clinical Consensus Statement of the Association for Acute CardioVascular Care (ACVC) of the ESC, the European Association of Percutaneous Cardiovascular In
    Eur Heart J. 2024 Jun 18:ehae363. doi: 10.1093.
    PubMed     Abstract available


  62. PEDICINO D, Volpe M
    Weekly Journal Scan: do we need beta-blockers after myocardial infarction with preserved ejection fraction?
    Eur Heart J. 2024 Jun 14:ehae368. doi: 10.1093.
    PubMed    


  63. COUGHLAN JJ, Durand R, Byrne RA
    An initial invasive strategy in older patients with non-ST elevation acute coronary syndromes: it is never too late.
    Eur Heart J. 2024;45:2063-2065.
    PubMed    


  64. KOTANIDIS CP, Mills GB, Bendz B, Berg ES, et al
    Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis.
    Eur Heart J. 2024;45:2052-2062.
    PubMed     Abstract available


  65. BEERKENS FJ, Bhatt DL
    Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: is a routine invasive strategy needed?
    Eur Heart J. 2024 Jun 7:ehae287. doi: 10.1093.
    PubMed    


  66. CULLEN L, Greenslade J, Parsonage W, Stephensen L, et al
    Point-of-care high-sensitivity cardiac troponin in suspected acute myocardial infarction assessed at baseline and 2 h.
    Eur Heart J. 2024 Jun 6:ehae343. doi: 10.1093.
    PubMed     Abstract available


  67. LIUZZO G, Patrono C
    Weekly Journal Scan: sodium/glucose cotransporter 2 inhibition after myocardial infarction still in the grey area.
    Eur Heart J. 2024 Jun 1:ehae304. doi: 10.1093.
    PubMed    


  68. VERGALLO R, Pedicino D
    Weekly Journal Scan: Impella CP in myocardial infarction complicated by cardiogenic shock.
    Eur Heart J. 2024 Jun 1:ehae306. doi: 10.1093.
    PubMed    


  69. UZOKOV J, Alyavi A, Alyavi B, Abdullaev A, et al
    How artificial intelligence can assist with ischaemic heart disease.
    Eur Heart J. 2024;45:1866-1868.
    PubMed    


    May 2024
  70. REN J, Bowyer A, Tian DH, Royse C, et al
    Multiple arterial vs. single arterial coronary artery bypass grafting: sex-related differences in outcomes.
    Eur Heart J. 2024 May 31:ehae294. doi: 10.1093.
    PubMed     Abstract available


  71. KELHAM M, Vyas R, Ramaseshan R, Rathod K, et al
    Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: a meta-analysis of invasive vs. conservative management.
    Eur Heart J. 2024 May 28:ehae245. doi: 10.1093.
    PubMed     Abstract available


  72. KWON O, Ahn JH, Koh JS, Park Y, et al
    Platelet-fibrin clot strength and platelet reactivity predicting cardiovascular events after percutaneous coronary interventions.
    Eur Heart J. 2024 May 28:ehae296. doi: 10.1093.
    PubMed     Abstract available


  73. CREA F
    The growing role of coronary computed tomography angiography, polygenic risk scores and electronic nudges in the management of ischaemic heart disease.
    Eur Heart J. 2024;45:1769-1773.
    PubMed    


  74. NURMOHAMED NS, van Rosendael AR, Danad I, Ngo-Metzger Q, et al
    Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography.
    Eur Heart J. 2024;45:1783-1800.
    PubMed     Abstract available


  75. HARIK L, Gaudino M
    Coronary angiography and bypass surgery: born together and now going separate ways?
    Eur Heart J. 2024;45:1816-1818.
    PubMed    


  76. SERRUYS PW, Kageyama S, Pompilio G, Andreini D, et al
    Coronary bypass surgery guided by computed tomography in a low-risk population.
    Eur Heart J. 2024;45:1804-1815.
    PubMed     Abstract available


  77. LEE YJ, Shin S, Kwon SW, Suh Y, et al
    Ticagrelor monotherapy for acute coronary syndrome: an individual patient data meta-analysis of TICO and T-PASS trials.
    Eur Heart J. 2024 May 16:ehae249. doi: 10.1093.
    PubMed     Abstract available


  78. DVIR D, Tchetche D, Leon MB, Genereux P, et al
    Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study.
    Eur Heart J. 2024 May 15:ehae303. doi: 10.1093.
    PubMed     Abstract available


  79. PAOLUCCI L, Mangiacapra F, Sergio S, Nusca A, et al
    Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis.
    Eur Heart J. 2024 May 14:ehae266. doi: 10.1093.
    PubMed     Abstract available


  80. CREA F
    Focus on ischaemic heart disease: prevention with colchicine, role of the brain-heart axis, new therapeutic targets for ischaemia-reperfusion injury.
    Eur Heart J. 2024;45:1577-1581.
    PubMed    


  81. TAKAHARA M, Soga Y, Iida O
    Lower extremity arterial disease vs. coronary artery disease: mortality differences after revascularization.
    Eur Heart J. 2024;45:1634-1643.
    PubMed     Abstract available


  82. AMPONSAH-OFFEH M, Tual-Chalot S, Stellos K
    Repurposing of an antiasthmatic drug may reduce NETosis and myocardial ischaemia/reperfusion injury.
    Eur Heart J. 2024;45:1681-1683.
    PubMed    


  83. YANG K, Gao R, Chen H, Hu J, et al
    Myocardial reperfusion injury exacerbation due to ALDH2 deficiency is mediated by neutrophil extracellular traps and prevented by leukotriene C4 inhibition.
    Eur Heart J. 2024;45:1662-1680.
    PubMed     Abstract available


  84. ADLAM D, van Dijk FS, Loeys B
    Genetic testing in patients with unexplained coronary aneurysms or dilation.
    Eur Heart J. 2024;45:1610-1612.
    PubMed    


  85. JONES DA, Beirne AM, Kelham M, Wynne L, et al
    Inorganic nitrate benefits contrast-induced nephropathy after coronary angiography for acute coronary syndromes: the NITRATE-CIN trial.
    Eur Heart J. 2024;45:1647-1658.
    PubMed     Abstract available


  86. XIAO Q, Xu Y, Wang S
    Gastropericardial fistula complicated by severe multi-vessel coronary spasm.
    Eur Heart J. 2024;45:1685.
    PubMed    


  87. CHEN Z, Dazard JE, Khalifa Y, Motairek I, et al
    Artificial intelligence-based assessment of built environment from Google Street View and coronary artery disease prevalence.
    Eur Heart J. 2024;45:1540-1549.
    PubMed     Abstract available


  88. HEUSCH G, Kleinbongard P
    Cardioprotection research has left its comfort zone.
    Eur Heart J. 2024;45:1568-1570.
    PubMed    


  89. VERGALLO R, Patrono C
    Weekly journal scan: intravascular imaging to guide percutaneous coronary intervention-ready for prime time?
    Eur Heart J. 2024 May 4:ehae242. doi: 10.1093.
    PubMed    


    April 2024
  90. NGO LTH, Peng Y, Denman R, Yang I, et al
    Long-term outcomes after hospitalization for atrial fibrillation or flutter.
    Eur Heart J. 2024 Apr 28:ehae204. doi: 10.1093.
    PubMed     Abstract available


  91. GALIUTO L, Volpe M
    Weekly journal scan: excess incidence of unexpected health outcomes following myocardial infarction-broader paths for secondary prevention.
    Eur Heart J. 2024 Apr 15:ehae229. doi: 10.1093.
    PubMed    


  92. BHATT AS, Johansen ND, Modin D, Claggett BL, et al
    Electronic nudges increase influenza vaccination utilization after myocardial infarction: the nationwide NUDGE-FLU implementation trial.
    Eur Heart J. 2024 Apr 10:ehae235. doi: 10.1093.
    PubMed    


  93. VERGALLO R, Galiuto L
    Weekly journal scan: angina severity reduced by percutaneous coronary intervention in the ORBITA-2 trial.
    Eur Heart J. 2024 Apr 10:ehae215. doi: 10.1093.
    PubMed    


  94. CREA F
    The complex interaction between cancer, ischaemic heart disease, and heart failure, and a focus on arrhythmias including risk stratification in Brugada syndrome and leadless pacing.
    Eur Heart J. 2024;45:1183-1187.
    PubMed    


  95. KASKI JC, Al-Lamee R, Boden WE
    The year in cardiovascular medicine 2023: the top 10 papers in ischaemic heart disease.
    Eur Heart J. 2024;45:1201-1204.
    PubMed    


  96. AMERI P, Bertero E, Lombardi M, Porto I, et al
    Ischaemic heart disease in patients with cancer.
    Eur Heart J. 2024;45:1209-1223.
    PubMed     Abstract available


  97. BYRNE R, Coughlan JJ, Rossello X, Ibanez B, et al
    The '10 commandments' for the 2023 ESC Guidelines for the management of acute coronary syndromes.
    Eur Heart J. 2024;45:1193-1195.
    PubMed    


  98. CALLEGARI A, Bonnet D, Malekzadeh-Milani S
    Successful percutaneous treatment of perinatal complete left coronary thrombotic occlusion.
    Eur Heart J. 2024;45:1285.
    PubMed    


  99. WU VC, Yeh JK, Chen SW, Wu CL, et al
    Syphilis and cardiovascular risk: a Taiwanese registry.
    Eur Heart J. 2024 Apr 3:ehae183. doi: 10.1093.
    PubMed     Abstract available


  100. SAYAH N, Bhatt DL, Miller M, Brinton EA, et al
    Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial.
    Eur Heart J. 2024;45:1173-1176.
    PubMed    


    March 2024
  101. LI L, Pang S, Starnecker F, Mueller-Myhsok B, et al
    Integration of a polygenic score into guideline-recommended prediction of cardiovascular disease.
    Eur Heart J. 2024 Mar 29:ehae048. doi: 10.1093.
    PubMed     Abstract available


  102. WYLD M, Webster AC
    Myocardial infarction and stroke in patients with kidney failure: can we do better?
    Eur Heart J. 2024 Mar 27:ehae153. doi: 10.1093.
    PubMed    


  103. TSUDA K, Nagamatsu W, Morii I
    A collateral channel from the bronchial artery in chronic total occlusion of proximal right coronary artery.
    Eur Heart J. 2024;45:1087.
    PubMed    


  104. VILAHUR G, Radike M, Sutelman P, Ben-Aicha S, et al
    Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective effects in experimental myocardial infarction.
    Eur Heart J. 2024 Mar 15:ehae107. doi: 10.1093.
    PubMed     Abstract available


  105. URSO S, Sadaba R, Dayan V
    Benefits of coronary artery bypass grafting over percutaneous coronary intervention in left main disease: the strength of the evidence.
    Eur Heart J. 2024 Mar 5:ehae135. doi: 10.1093.
    PubMed    


  106. VERGALLO R, Galiuto L
    Weekly journal scan: do biodegradable polymer stents provide a durable benefit in patients with ST-segment elevation myocardial infarction?
    Eur Heart J. 2024 Mar 4:ehae119. doi: 10.1093.
    PubMed    


  107. GALLACHER PJ, Yeung D, Bell S, Shah ASV, et al
    Kidney replacement therapy: trends in incidence, treatment, and outcomes of myocardial infarction and stroke in a nationwide Scottish study.
    Eur Heart J. 2024 Mar 1:ehae080. doi: 10.1093.
    PubMed     Abstract available


  108. CREA F
    Ischaemic heart disease: prevention, management, mechanisms, and new therapeutic targets.
    Eur Heart J. 2024;45:637-641.
    PubMed    


  109. JANSEN TPJ, Wentzel JJ, Damman P
    Interplay between coronary bridging and high shear stress in the emergence of coronary vasospasm.
    Eur Heart J. 2024;45:737.
    PubMed    


    February 2024
  110. KUMAR A, Vora K, Bhatt DL, Dharmakumar R, et al
    The Canadian Cardiovascular Society Classification of acute atherothrombotic myocardial infarction provides a novel staging scheme based on tissue injury severity.
    Eur Heart J. 2024 Feb 17:ehad821. doi: 10.1093.
    PubMed    


  111. TARANTINI G, Putorti F, Nai Fovino L
    10-Year optical coherence tomography follow-up of 'full-plastic jacket' with bioresorbable vascular scaffolds.
    Eur Heart J. 2024;45:556.
    PubMed    


  112. BARILE L, Marban E
    Injury minimization after myocardial infarction: focus on extracellular vesicles.
    Eur Heart J. 2024 Feb 15:ehae089. doi: 10.1093.
    PubMed     Abstract available


  113. NISHIHIRA K, Asano Y, Shibata Y
    Efficacy of paclitaxel-coated balloon angioplasty combined with intensive lipid-lowering therapy for ST-segment elevation myocardial infarction: insights from near-infrared spectroscopy.
    Eur Heart J. 2024 Feb 15:ehae073. doi: 10.1093.
    PubMed    


  114. HOLT A, Nouhravesh N, Strange JE, Kinnberg Nielsen S, et al
    Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study.
    Eur Heart J. 2024;45:475-484.
    PubMed     Abstract available


  115. MONTONE RA, Camilli M, Calvieri C, Magnani G, et al
    Exposome in ischaemic heart disease: beyond traditional risk factors.
    Eur Heart J. 2024;45:419-438.
    PubMed     Abstract available


  116. CHEONG HS, Chang Y, Kim Y, Kwon MJ, et al
    Human papillomavirus infection and cardiovascular mortality: a cohort study.
    Eur Heart J. 2024 Feb 7:ehae020. doi: 10.1093.
    PubMed     Abstract available


  117. THYREGOD HGH, Jorgensen TH, Ihlemann N, Steinbruchel DA, et al
    Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.
    Eur Heart J. 2024 Feb 7:ehae043. doi: 10.1093.
    PubMed     Abstract available


  118. BOERHOUT CKM, Piek JJ, van de Hoef TP
    The microvascular resistance reserve: one size fits all, but mostly one.
    Eur Heart J. 2024;45:401.
    PubMed    


  119. JANSEN TPJ, Crooijmans C, Damman P
    Microvascular resistance reserve, does one size fit all?
    Eur Heart J. 2024;45:399-400.
    PubMed    


    January 2024
  120. HUET F, Mariano-Goulart D, Aguilhon S, Delbaere Q, et al
    Colchicine to prevent sympathetic denervation after acute myocardial infarction: the COLD-MI trial.
    Eur Heart J. 2024 Jan 30:ehae042. doi: 10.1093.
    PubMed    


  121. SENIOR R, Khattar RS
    To test or not to test for ischaemia routinely after percutaneous coronary intervention in diabetic patients: is the jury still out?
    Eur Heart J. 2024 Jan 30:ehad877. doi: 10.1093.
    PubMed    


  122. NAKAJIMA A, Okutsu M, Nakamura S
    Optical coherence tomographic patterns of restenosis in patients treated with directional coronary atherectomy and drug-coated balloon therapy.
    Eur Heart J. 2024;45:315.
    PubMed    


  123. NATARAJAN N, Dutta P
    'Training' of innate immunity following myocardial infarction exacerbates atherosclerosis.
    Eur Heart J. 2024 Jan 25:ehae024. doi: 10.1093.
    PubMed    


  124. PERSITS I, Layoun H, Kondoleon NP, Spilias N, et al
    Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement.
    Eur Heart J. 2024 Jan 25:ehae019. doi: 10.1093.
    PubMed     Abstract available


  125. GOBEIL E, Bourgault J, Mitchell PL, Houessou U, et al
    Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic risk.
    Eur Heart J. 2024 Jan 19:ehad845. doi: 10.1093.
    PubMed     Abstract available


  126. ARNOLD N, Blaum C, Gossling A, Brunner FJ, et al
    C-reactive protein modifies lipoprotein(a)-related risk for coronary heart disease: the BiomarCaRE project.
    Eur Heart J. 2024 Jan 18:ehad867. doi: 10.1093.
    PubMed     Abstract available


  127. LI Z, Zhang H, Lin S
    Functionally bicuspid aortic valve leads to myocardial ischaemia.
    Eur Heart J. 2024 Jan 18:ehad891. doi: 10.1093.
    PubMed    


  128. VERGALLO R, Galiuto L
    Shedding the optical coherence tomography light on the treatment of complex coronary bifurcation lesions.
    Eur Heart J. 2024;45:159-160.
    PubMed    


  129. GOULD KL, Johnson NP, Roby AE, Bui L, et al
    Coronary flow capacity and survival prediction after revascularization: physiological basis and clinical implications.
    Eur Heart J. 2024;45:181-194.
    PubMed     Abstract available


  130. SHIMADA T, Otsuka K, Fukuda D
    Acute thrombus formation following stent implantation diagnosed by using intravascular polarimetry.
    Eur Heart J. 2024;45:145.
    PubMed    


  131. CAMARO C, Aarts GWA, van Royen N
    Less concern about missing NSTEMIs, more prospective randomized controlled trials warranted.
    Eur Heart J. 2024;45:144.
    PubMed    


  132. GLAESER J, Lopez-Ayala P, Mueller C
    Concern regarding missed non-ST-segment elevation myocardial infarctions when applying a single, pre-hospital cardiac troponin measurement.
    Eur Heart J. 2024;45:142-143.
    PubMed    


  133. CREA F
    The key role of thrombosis: focus on acute coronary syndrome, venous thrombo-embolism, and atrial fibrillation.
    Eur Heart J. 2024;45:1-4.
    PubMed    


  134. BAATEN CCFMJ, Nagy M, Bergmeier W, Spronk HMH, et al
    Platelet biology and function: plaque erosion vs. rupture.
    Eur Heart J. 2024;45:18-31.
    PubMed     Abstract available


    December 2023
  135. TAQUETI VR
    Leveraging global coronary flow assessments to inform revascularization benefit in chronic coronary disease: time to test total heart flow.
    Eur Heart J. 2023 Dec 28:ehad812. doi: 10.1093.
    PubMed    


  136. PEDICINO D, Vergallo R
    More blood for patients with myocardial infarction and anaemia?
    Eur Heart J. 2023 Dec 23:ehad832. doi: 10.1093.
    PubMed    


  137. REDD MA, Yoshikawa Y, Khan N, Waqar M, et al
    Acid-sensing ion channel 1a blockade reduces myocardial injury in rodent models of myocardial infarction.
    Eur Heart J. 2023 Dec 14:ehad793. doi: 10.1093.
    PubMed    


  138. PIRIOU PG, Plessis J, Guerin P
    Transcatheter aortic valve replacement in patients with cardiogenic shock: safe and effective, but the most critical patients require further investigations.
    Eur Heart J. 2023 Dec 14:ehad808. doi: 10.1093.
    PubMed    


  139. DONG Z, Hou L, Luo W, Pan LH, et al
    Myocardial infarction drives trained immunity of monocytes, accelerating atherosclerosis.
    Eur Heart J. 2023 Dec 12:ehad787. doi: 10.1093.
    PubMed     Abstract available


  140. KHAN MS, Usman MS, Van Spall HGC, Greene SJ, et al
    Endpoint adjudication in cardiovascular clinical trials.
    Eur Heart J. 2023;44:4835-4846.
    PubMed     Abstract available


  141. ALFONSO F, Marschall A, Rivero F
    Revascularization for left main coronary artery disease.
    Eur Heart J. 2023;44:4893.
    PubMed    


  142. PERSSON J, Ivert T, Omerovic E
    Observational studies are needed to complete the body of evidence for left main coronary artery disease revascularization strategies.
    Eur Heart J. 2023;44:4894.
    PubMed    


    November 2023
  143. LU ZN, Yang Y, Song G
    A patient-tailored clipping strategy of transcatheter edge-to-edge repair as salvage for cardiogenic shock complicated by mitral valve cleft and bileaflet flails.
    Eur Heart J. 2023 Nov 29:ehad802. doi: 10.1093.
    PubMed    


  144. VERGALLO R, Volpe M
    Optical coherence tomography to guide percutaneous coronary intervention: is the glass half full or half empty?
    Eur Heart J. 2023 Nov 28:ehad792. doi: 10.1093.
    PubMed    


  145. WENZL FA, Fox KAA, Luscher TF
    Towards personalized cardiovascular care: Global Registry of Acute Coronary Events 3.0 score heralds artificial intelligence era.
    Eur Heart J. 2023;44:4615-4616.
    PubMed    


  146. PEDICINO D, Vergallo R
    Routine use of extracorporeal life support in cardiogenic shock after acute myocardial infarction: the jury is still out.
    Eur Heart J. 2023 Nov 18:ehad760. doi: 10.1093.
    PubMed    


  147. PEDICINO D, Liuzzo G
    Does MULTISTARS shed light on the timing of complete revascularization in ST-elevation myocardial infarction?
    Eur Heart J. 2023 Nov 18:ehad733. doi: 10.1093.
    PubMed    


  148. LIU W, Song B, Li B
    Myocardial infarction caused by in situ thrombosis of a patent foramen ovale assessed by optical coherence tomography.
    Eur Heart J. 2023 Nov 15:ehad753. doi: 10.1093.
    PubMed    


  149. HENRY CM, Oseran AS, Zheng Z, Dong H, et al
    Cardiovascular Hospitalizations and Mortality Among Adults Aged 25 to 64 years in the United States.
    Eur Heart J. 2023 Nov 11:ehad772. doi: 10.1093.
    PubMed     Abstract available


  150. LUO J, Thomassen JQ, Nordestgaard BG, Tybjaerg-Hansen A, et al
    Neutrophil counts and cardiovascular disease.
    Eur Heart J. 2023 Nov 9:ehad649. doi: 10.1093.
    PubMed     Abstract available


  151. DEMIDOVA MM, Holmqvist F, Erlinge D, Platonov PG, et al
    Ventricular arrhythmias during ST-segment elevation myocardial infarction and arrhythmic complications during recurrent ischaemic events.
    Eur Heart J. 2023 Nov 3:ehad740. doi: 10.1093.
    PubMed    


  152. KIM H, Kang DY, Lee J, Choi Y, et al
    Routine stress testing in diabetic patients after percutaneous coronary intervention: the POST-PCI trial.
    Eur Heart J. 2023 Nov 2:ehad722. doi: 10.1093.
    PubMed     Abstract available


  153. CREA F
    Hot topics in interventional cardiology: left main disease, heavily calcified coronary stenoses, and physiology-guided percutaneous coronary interventions.
    Eur Heart J. 2023;44:4295-4299.
    PubMed    


  154. ALASNAG M
    Instantaneous wave-free ratio compared with fractional flow reserve: time for rethinking current recommendations.
    Eur Heart J. 2023;44:4385-4387.
    PubMed    


  155. BYRNE RA, Fremes S, Capodanno D, Czerny M, et al
    2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.
    Eur Heart J. 2023;44:4310-4320.
    PubMed     Abstract available


  156. JOHNSON NP, Ahn JM
    Left main PCI: beware the circumflex!
    Eur Heart J. 2023;44:4337-4339.
    PubMed    


  157. BARBATO E, Gallinoro E, Abdel-Wahab M, Andreini D, et al
    Management strategies for heavily calcified coronary stenoses: an EAPCI clinical consensus statement in collaboration with the EURO4C-PCR group.
    Eur Heart J. 2023;44:4340-4356.
    PubMed     Abstract available


  158. WANG HY, Zhang R, Dou K, Huang Y, et al
    Left main bifurcation stenting: impact of residual ischaemia on cardiovascular mortality.
    Eur Heart J. 2023;44:4324-4336.
    PubMed     Abstract available


    October 2023
  159. NAMBIEMA A, Lisan Q, Vaucher J, Perier MC, et al
    Healthy sleep score changes and incident cardiovascular disease in European prospective community-based cohorts.
    Eur Heart J. 2023 Oct 20:ehad657. doi: 10.1093.
    PubMed     Abstract available


  160. ARORA S, Zimmermann FM, Solberg OG, Nytroen K, et al
    Prognostic value of intravascular ultrasound early after heart transplantation.
    Eur Heart J. 2023 Oct 18:ehad648. doi: 10.1093.
    PubMed    


  161. CREA F
    Acute coronary syndromes: new guidelines and new light shed on biomarkers and mechanisms of plaque instability.
    Eur Heart J. 2023;44:3707-3711.
    PubMed    


  162. WENZL FA, Bruno F, Kraler S, Klingenberg R, et al
    Dipeptidyl peptidase 3 plasma levels predict cardiogenic shock and mortality in acute coronary syndromes.
    Eur Heart J. 2023;44:3859-3871.
    PubMed     Abstract available


  163. NISSEN SE
    Plaque morphology, inflammation, and outcome: cautious and tempered interpretation warranted.
    Eur Heart J. 2023;44:3926-3928.
    PubMed    


  164. GERHARDT T, Seppelt C, Abdelwahed YS, Meteva D, et al
    Culprit plaque morphology determines inflammatory risk and clinical outcomes in acute coronary syndrome.
    Eur Heart J. 2023;44:3911-3925.
    PubMed     Abstract available


  165. METEVA D, Vinci R, Seppelt C, Abdelwahed YS, et al
    Toll-like receptor 2, hyaluronan, and neutrophils play a key role in plaque erosion: the OPTICO-ACS study.
    Eur Heart J. 2023;44:3892-3907.
    PubMed     Abstract available


  166. FRANCK G
    Unravelling the heart's comic drama: can TLRs and hyaluronan metabolism stoke neutrophil rage in acute coronary syndrome?
    Eur Heart J. 2023;44:3908-3910.
    PubMed    


  167. EMMERT MY, Burrello J, Wolint P, Hilbe M, et al
    Intracoronary delivery of extracellular vesicles from human cardiac progenitor cells reduces infarct size in porcine acute myocardial infarction.
    Eur Heart J. 2023 Oct 3:ehad636. doi: 10.1093.
    PubMed    


  168. PEDICINO D, Liuzzo G
    An unexpected fall from GRACE.
    Eur Heart J. 2023;44:3501-3502.
    PubMed    


    September 2023
  169. VERGALLO R, Volpe M
    Light the FIRE of revascularization in older patients with myocardial infarction.
    Eur Heart J. 2023 Sep 28:ehad638. doi: 10.1093.
    PubMed    


  170. KI YJ, Han K, Kim HS, Han JK, et al
    Smoking and cardiovascular outcomes after percutaneous coronary intervention: a Korean study.
    Eur Heart J. 2023 Sep 26:ehad616. doi: 10.1093.
    PubMed     Abstract available


  171. WEINTRAUB WS, Boden WE
    Can we measurably improve the prediction of recurrent coronary artery disease events?
    Eur Heart J. 2023;44:3466-3468.
    PubMed    


  172. CREA F
    Challenges and opportunities in prognostication: focus on ischaemic heart disease and atrial fibrillation.
    Eur Heart J. 2023;44:3391-3394.
    PubMed    


  173. CHO SMJ, Koyama S, Honigberg MC, Surakka I, et al
    Genetic, sociodemographic, lifestyle, and clinical risk factors of recurrent coronary artery disease events: a population-based cohort study.
    Eur Heart J. 2023;44:3456-3465.
    PubMed     Abstract available


  174. ARDISSINO M, Morley AP, Slob EAW, Schuermans A, et al
    Birth weight influences cardiac structure, function, and disease risk: evidence of a causal association.
    Eur Heart J. 2023 Sep 20:ehad631. doi: 10.1093.
    PubMed     Abstract available


  175. CREA F
    TAVI or non-TAVI in asymptomatic aortic stenosis, in cardiogenic shock, and in patients with Heyde syndrome?
    Eur Heart J. 2023;44:3105-3109.
    PubMed    


    August 2023
  176. BERRY C, McClure JD, Oldroyd KG
    Coronary revascularization guided by instantaneous wave-free ratio compared to fractional flow reserve: pooled 5-year mortality in the DEFINE-FLAIR and iFR-SWEDEHEART trials.
    Eur Heart J. 2023 Aug 27:ehad552. doi: 10.1093.
    PubMed    


  177. EFTEKHARI A, Holck EN, Westra J, Olsen NT, et al
    Five-year major cardiovascular events are increased when coronary revascularization is guided by instantaneous wave-free ratio compared to fractional flow reserve: a pooled analysis of iFR-SWEDEHEART and DEFINE-FLAIR trials.
    Eur Heart J. 2023 Aug 27:ehad582. doi: 10.1093.
    PubMed     Abstract available


  178. GAUTIER A, Picard F, Ducrocq G, Elbez Y, et al
    New-onset atrial fibrillation in chronic coronary syndrome: the CLARIFY registry.
    Eur Heart J. 2023 Aug 27:ehad556. doi: 10.1093.
    PubMed     Abstract available


  179. BYRNE RA, Rossello X, Coughlan JJ, Barbato E, et al
    2023 ESC Guidelines for the management of acute coronary syndromes.
    Eur Heart J. 2023 Aug 25:ehad191. doi: 10.1093.
    PubMed    


  180. RAO S, Nazarzadeh M, Canoy D, Li Y, et al
    Sodium-based paracetamol: impact on blood pressure, cardiovascular events, and all-cause mortality.
    Eur Heart J. 2023 Aug 23:ehad535. doi: 10.1093.
    PubMed     Abstract available


  181. CAPODANNO D, Angiolillo DJ
    Personalised antiplatelet therapies for coronary artery disease: what the future holds.
    Eur Heart J. 2023;44:3059-3072.
    PubMed     Abstract available


  182. AARTS GWA, Camaro C, van Royen N
    Ready for rapid rule-out of acute myocardial infarction.
    Eur Heart J. 2023 Aug 18:ehad519. doi: 10.1093.
    PubMed    


  183. MATTER MA, Paneni F, Libby P, Frantz S, et al
    Inflammation in acute myocardial infarction: the good, the bad and the ugly.
    Eur Heart J. 2023 Aug 17:ehad486. doi: 10.1093.
    PubMed     Abstract available


  184. PRENDERGAST BD, Patterson T, Redwood S
    Transcatheter aortic valve implantation in patients with severe aortic stenosis and cardiogenic shock: an important step forward.
    Eur Heart J. 2023 Aug 10:ehad471. doi: 10.1093.
    PubMed    


  185. CREA F
    Coronary microvascular dysfunction: from Cinderella to Princess.
    Eur Heart J. 2023;44:2791-2794.
    PubMed    


  186. KATUS HA, Giannitsis E
    Single high-sensitivity troponin sample below the limit of detection to safely rule out NSTEMI-ACS: is this enough?
    Eur Heart J. 2023;44:2859-2861.
    PubMed    


  187. MORROW AJ, McFarlane R, Berry C
    Novel therapy for ischaemia with no obstructive coronary arteries.
    Eur Heart J. 2023;44:2829-2832.
    PubMed    


  188. ENDAMENA GB, Le Moal J, Landolff Q
    Fast healing of an almost complete iatrogenic ascending aortic hematoma post-percutaneous recanalization for chronic total occlusion.
    Eur Heart J. 2023;44:2875.
    PubMed    


  189. MCENTEGART M, Gori T
    How to treat left main coronary artery disease: the complementary lessons from trials and registries.
    Eur Heart J. 2023;44:2843-2845.
    PubMed    


  190. PERSSON J, Yan J, Angeras O, Venetsanos D, et al
    PCI or CABG for left main coronary artery disease: the SWEDEHEART registry.
    Eur Heart J. 2023;44:2833-2842.
    PubMed     Abstract available


  191. ACHIM A, Johnson NP, Liblik K, Burckhardt A, et al
    Coronary steal: how many thieves are out there?
    Eur Heart J. 2023;44:2805-2814.
    PubMed     Abstract available


  192. AL ZAIDI M, Nickenig G, Zimmer S
    Emergency transcatheter aortic valve replacement in a 35-year-old patient with unicuspid aortic valve disease and cardiogenic shock.
    Eur Heart J. 2023 Aug 2:ehad465. doi: 10.1093.
    PubMed    


  193. LIUZZO G, Patrono C
    Acute myocardial infarction is associated with faster age-related cognitive decline.
    Eur Heart J. 2023 Aug 1:ehad475. doi: 10.1093.
    PubMed    


  194. VERGALLO R, Patrono C
    Machine learning and myocardial infarction diagnosis: sometimes you can't make it on your own.
    Eur Heart J. 2023 Aug 1:ehad467. doi: 10.1093.
    PubMed    


  195. SANCHEZ-CABO F, Fuster V, Silla-Castro JC, Gonzalez G, et al
    Subclinical atherosclerosis and accelerated epigenetic age mediated by inflammation: a multi-omics study.
    Eur Heart J. 2023;44:2698-2709.
    PubMed     Abstract available


  196. VAN KLEI WA, van Waes JAR, Beattie WS
    Routine post-operative troponin surveillance after non-cardiac surgery: are we ready?
    Eur Heart J. 2023 Aug 1:ehad487. doi: 10.1093.
    PubMed    


  197. ROHDE LE, McMurray JJV
    REVIV(E)ing the ischaemic paradigm in heart failure: STICHes are needed.
    Eur Heart J. 2023 Aug 1:ehad488. doi: 10.1093.
    PubMed    


    July 2023
  198. PEDERSEN CK, Stengaard C, Botker MT, Sondergaard HM, et al
    Accelerated -Rule-Out of acute Myocardial Infarction using prehospital copeptin and in-hospital troponin: The AROMI study.
    Eur Heart J. 2023 Jul 21:ehad447. doi: 10.1093.
    PubMed     Abstract available


  199. DE LEMOS JA, Berry JD
    Comparisons of multiple troponin assays for detecting chronic myocardial injury in the general population: redundant or complementary?
    Eur Heart J. 2023;44:2606-2608.
    PubMed    


  200. DEL VAL D, Bastante T, Alfonso F
    A novel coronary artery healing pattern suggesting the axial progression of coronary plaques.
    Eur Heart J. 2023;44:2643.
    PubMed    


  201. FAZEL R, Yeh RW, Cohen DJ, Rao SV, et al
    Intravascular imaging during percutaneous coronary intervention: temporal trends and clinical outcomes in the USA.
    Eur Heart J. 2023 Jul 19:ehad430. doi: 10.1093.
    PubMed     Abstract available


  202. PEDICINO D, Liuzzo G
    Should I stent or should I go?
    Eur Heart J. 2023;44:2425-2426.
    PubMed    


  203. CREA F
    Focus on ischaemic heart disease: from mechanisms to prevention and treatment.
    Eur Heart J. 2023;44:2351-2354.
    PubMed    


  204. RUSSO M, Rinaldi R, Camilli M, Bonanni A, et al
    Air pollution and plaque healing in acute coronary syndromes.
    Eur Heart J. 2023;44:2403-2405.
    PubMed    


  205. FYYAZ S, Papadakis M
    Fit to a fault? The paradox of coronary artery disease in veteran athletes.
    Eur Heart J. 2023;44:2400-2402.
    PubMed    


  206. FREITAG MT, Haaf P, Zellweger MJ
    Severe myocardial ischemia detected in routine oncological positron emission tomography/computed tomography with 18F-fluorodeoxyglucose.
    Eur Heart J. 2023;44:2412.
    PubMed    


  207. BERRY C, Kramer CM, Kunadian V, Patel TR, et al
    Great Debate: Computed tomography coronary angiography should be the initial diagnostic test in suspected angina.
    Eur Heart J. 2023;44:2366-2375.
    PubMed    


  208. DE BOSSCHER R, Dausin C, Claus P, Bogaert J, et al
    Lifelong endurance exercise and its relation with coronary atherosclerosis.
    Eur Heart J. 2023;44:2388-2399.
    PubMed     Abstract available


  209. MENTE A, Dehghan M, Rangarajan S, O'Donnell M, et al
    Diet, cardiovascular disease, and mortality in 80 countries.
    Eur Heart J. 2023 Jul 6:ehad269. doi: 10.1093.
    PubMed     Abstract available


    June 2023
  210. BJORNSON E, Adiels M, Taskinen MR, Burgess S, et al
    Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study.
    Eur Heart J. 2023 Jun 26:ehad337. doi: 10.1093.
    PubMed     Abstract available


  211. CANDREVA A, Templin C
    Is Takotsubo syndrome just the tip of the iceberg in the clinical spectrum of coronary microvascular dysfunction?
    Eur Heart J. 2023;44:2254-2256.
    PubMed    


  212. DONG F, Yin L, Sisakian H, Hakobyan T, et al
    Takotsubo syndrome is a coronary microvascular disease: experimental evidence.
    Eur Heart J. 2023;44:2244-2253.
    PubMed     Abstract available


  213. LOWRY MTH, Doudesis D, Boeddinghaus J, Kimenai DM, et al
    Troponin in early presenters to rule out myocardial infarction.
    Eur Heart J. 2023 Jun 23:ehad376. doi: 10.1093.
    PubMed     Abstract available


  214. SOURIJ H, Aziz F, Mangge H, von Lewinski D, et al
    SGLT2 inhibition could potentially impact inflammation in acute myocardial infarction.
    Eur Heart J. 2023 Jun 23:ehad404. doi: 10.1093.
    PubMed    


  215. TRIMAILLE A, Marchandot B, Morel O
    Modulation of inflammatory response after myocardial infarction: one explanation for the cardiovascular benefit of empagliflozin in the EMMY trial?
    Eur Heart J. 2023 Jun 23:ehad257. doi: 10.1093.
    PubMed    


  216. BOERHOUT CKM, Lee JM, de Waard GA, Mejia-Renteria H, et al
    Microvascular resistance reserve: diagnostic and prognostic performance in the ILIAS registry.
    Eur Heart J. 2023 Jun 23:ehad378. doi: 10.1093.
    PubMed     Abstract available


  217. GOEL K, Shah P, Jones BM, Korngold E, et al
    Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock.
    Eur Heart J. 2023 Jun 23:ehad387. doi: 10.1093.
    PubMed     Abstract available


  218. NEMET I, Li XS, Haghikia A, Li L, et al
    Atlas of gut microbe-derived products from aromatic amino acids and risk of cardiovascular morbidity and mortality.
    Eur Heart J. 2023 Jun 21:ehad333. doi: 10.1093.
    PubMed     Abstract available


  219. ALEXANDRE A, Silveira J, Sa I
    Chronic intramyocardial dissecting haematoma: multimodality imaging.
    Eur Heart J. 2023;44:2132.
    PubMed    


  220. AMIN H, Noor HA, Bardooli F, Yousif N, et al
    Implementation of a national primary percutaneous coronary intervention program for ST-segment elevation myocardial infarction in the Kingdom of Bahrain: an inspiring success story from a centre of excellence.
    Eur Heart J. 2023 Jun 17:ehad329. doi: 10.1093.
    PubMed    


  221. SABOURET P, Biondi-Zoccai G, Banach M, Galli M, et al
    Modulation and personalization of therapy after acute coronary syndromes: the road to precision.
    Eur Heart J. 2023;44:1965-1967.
    PubMed    


  222. VERGALLO R, Patrono C
    Lower income, higher risk: disparities in treatments and outcomes of patients with acute myocardial infarction.
    Eur Heart J. 2023 Jun 2:ehad348. doi: 10.1093.
    PubMed    


    May 2023
  223. CREA F
    Ischaemic heart disease: from the celebration of Heberden's description of angina pectoris to novel therapeutic targets for angiogenesis and myocardial fibrosis.
    Eur Heart J. 2023;44:1669-1673.
    PubMed    


  224. HEUSCH G, Botker HE, Ferdinandy P, Schulz R, et al
    Primordial non-responsiveness: a neglected obstacle to cardioprotection.
    Eur Heart J. 2023;44:1687-1689.
    PubMed    


  225. GIGANTE B
    To be or not to be admitted to the emergency department for chest pain? A costly dilemma.
    Eur Heart J. 2023;44:1715-1717.
    PubMed    


  226. ZHU D, Liu S, Huang K, Li J, et al
    Intrapericardial long non-coding RNA-Tcf21 antisense RNA inducing demethylation administration promotes cardiac repair.
    Eur Heart J. 2023;44:1748-1760.
    PubMed     Abstract available


  227. IDING A, Ten Cate-Hoek A, Ten Cate H
    Determining 'thrombogenicity' in patients with coronary artery disease: what's next?
    Eur Heart J. 2023;44:1729-1731.
    PubMed    


  228. NISHI T, Kume T, Uemura S
    Resuscitated sudden cardiac arrest related to intraplaque haemorrhage and coronary artery spasm.
    Eur Heart J. 2023;44:1766.
    PubMed    


  229. BAO XL, Dai Y, Lu L, Wang XQ, et al
    Vasostatin-2 associates with coronary collateral vessel formation in diabetic patients and promotes angiogenesis via angiotensin-converting enzyme 2.
    Eur Heart J. 2023;44:1732-1744.
    PubMed     Abstract available


  230. CAMARO C, Aarts GWA, Adang EMM, van Hout R, et al
    Rule-out of non-ST-segment elevation acute coronary syndrome by a single, pre-hospital troponin measurement: a randomized trial.
    Eur Heart J. 2023;44:1705-1714.
    PubMed     Abstract available


  231. BODEN WE, Kaski JC, Berry C
    Reprising Heberden's description of angina pectoris after 250 years.
    Eur Heart J. 2023;44:1684-1686.
    PubMed    


  232. EMRICH T, Hell M
    Plaque composition on ultra-high-resolution coronary computed tomography angiography with optical coherence tomography correlation.
    Eur Heart J. 2023;44:1765.
    PubMed    


  233. VERGALLO R, Patrono C
    'Atom Heart Mothers': the risk of ischaemic heart disease in women with adverse pregnancy outcomes.
    Eur Heart J. 2023;44:1592-1593.
    PubMed    


  234. HAN Y
    Chinese expert consensus on clinical application of percutaneous mechanical circulatory support devices in interventional therapy for patients with complex cardiovascular disease.
    Eur Heart J. 2023;44:1586-1588.
    PubMed    


  235. UEMATSU M, Yamada R, Sato A
    Isolated septal myocardial infarction with non-obstructive coronary arteries.
    Eur Heart J. 2023 May 4:ehad252. doi: 10.1093.
    PubMed    


    April 2023
  236. BEN-BARUCH GOLAN Y, Zahger D
    Routine troponin testing before non-cardiac surgery: does the evidence justify the consequences?
    Eur Heart J. 2023 Apr 26:ehad227. doi: 10.1093.
    PubMed    


  237. VERGALLO R, Liuzzo G
    Intravascular imaging to guide percutaneous coronary intervention of complex lesions: time to renovate guidelines?
    Eur Heart J. 2023 Apr 26:ehad243. doi: 10.1093.
    PubMed    


  238. LIAKOPOULOS OJ, Kuhn EW, Hellmich M, Schlomicher M, et al
    Statin loading before coronary artery bypass grafting: a randomized trial.
    Eur Heart J. 2023 Apr 22:ehad238. doi: 10.1093.
    PubMed     Abstract available


  239. GENEST J
    Transient very low LDL-C levels: a legacy effect for cardiovascular prevention?
    Eur Heart J. 2023;44:1418-1420.
    PubMed    


  240. WADSTROM BN, Pedersen KM, Wulff AB, Nordestgaard BG, et al
    Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality.
    Eur Heart J. 2023;44:1432-1445.
    PubMed     Abstract available


  241. CREA F
    Persistent challenges following percutaneous interventions: paravalvular regurgitation, in-stent restenosis, and antiplatelet treatment-related bleeding.
    Eur Heart J. 2023;44:1287-1290.
    PubMed    


  242. KANG J, Rizas KD, Park KW, Chung J, et al
    Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis.
    Eur Heart J. 2023;44:1360-1370.
    PubMed     Abstract available


  243. NDREPEPA G, Kastrati A
    P2Y12 inhibitor intensity de-escalation in patients with acute coronary syndromes.
    Eur Heart J. 2023;44:1371-1373.
    PubMed    


  244. GIACOPPO D, Alvarez-Covarrubias HA, Koch T, Cassese S, et al
    Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial.
    Eur Heart J. 2023;44:1343-1357.
    PubMed     Abstract available


  245. GENTILE D, Iannaccone M, Chieffo A
    Drug-coated balloons: from treatment of in-stent restenosis to extended indications. What's next?
    Eur Heart J. 2023;44:1357-1359.
    PubMed    


  246. FEDELE D, Foa A, Pizzi C
    Electrocardiographic tips in a young woman presenting with ST-elevation myocardial infarction.
    Eur Heart J. 2023 Apr 11:ehad178. doi: 10.1093.
    PubMed    


  247. COLOMBO A, Leone PP
    Redefining the way to perform percutaneous coronary intervention: a view in search of evidence.
    Eur Heart J. 2023 Apr 11:ehad215. doi: 10.1093.
    PubMed    


  248. PEDICINO D, Volpe M
    Higher hospital readmissions in blacks after acute myocardial infarction: healthcare inequality gaps to fill in secondary prevention.
    Eur Heart J. 2023 Apr 10:ehad179. doi: 10.1093.
    PubMed    


  249. HIRANO KI, Higashi M, Nakajima K
    Remarkable regression of diffuse coronary atherosclerosis in patients with triglyceride deposit cardiomyovasculopathy.
    Eur Heart J. 2023;44:1191.
    PubMed    


    March 2023
  250. NURMOHAMED NS, Kraaijenhof JM, Mayr M, Nicholls SJ, et al
    Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction.
    Eur Heart J. 2023 Mar 29:ehad161. doi: 10.1093.
    PubMed     Abstract available


  251. SAKAI K, Collet C, Matsuo H
    Improvement of angina after treating focal coronary artery disease undetected in resting conditions.
    Eur Heart J. 2023;44:1097.
    PubMed    


  252. LIUZZO G, Patrono C
    Allopurinol does not improve cardiovascular outcomes in ischaemic heart disease.
    Eur Heart J. 2023;44:1016-1017.
    PubMed    


  253. CIARDETTI N, Nardi G, Di Mario C
    Direct high-frequency intravascular ultrasound visualization of drug delivery after paclitaxel urea eluting balloon angioplasty.
    Eur Heart J. 2023;44:1096.
    PubMed    


  254. HONDA Y, Nishihira K, Shibata Y, Asada Y, et al
    Early-phase restenosis following directional coronary atherectomy and paclitaxel-coated balloon angioplasty: a histopathological analysis.
    Eur Heart J. 2023;44:1098.
    PubMed    


  255. THIELE H, Desch S, Freund A
    Out-of-hospital cardiac arrest without ST-segment elevation: an alternative focus on priorities?
    Eur Heart J. 2023;44:1055-1057.
    PubMed    


  256. JIANG Y, Huang J, Li G, Wang W, et al
    Ozone pollution and hospital admissions for cardiovascular events.
    Eur Heart J. 2023 Mar 10:ehad091. doi: 10.1093.
    PubMed     Abstract available


  257. OZKAN J
    Patient study highlights the need to talk about INOCA.
    Eur Heart J. 2023;44:788-789.
    PubMed    


  258. SHEMESH E, Chevli PA, Islam T, German CA, et al
    Circulating ketone bodies and cardiovascular outcomes: the MESA study.
    Eur Heart J. 2023 Mar 6:ehad087. doi: 10.1093.
    PubMed     Abstract available


  259. LEE SH, Kim HK, Ahn JH, Kang MG, et al
    Prognostic impact of hypercoagulability and impaired fibrinolysis in acute myocardial infarction.
    Eur Heart J. 2023 Mar 1:ehad088. doi: 10.1093.
    PubMed     Abstract available


  260. HOJO K, Otsuka K, Kasayuki N
    Plaque rupture after coronary CT angiography.
    Eur Heart J. 2023;44:782.
    PubMed    


  261. MAJMUNDAR M, Doshi R, Patel KN, Zala H, et al
    Prevalence, trends, and outcomes of cardiovascular diseases in pregnant patients in the USA: 2010-19.
    Eur Heart J. 2023;44:726-737.
    PubMed     Abstract available


    February 2023

  262. Corrigendum to: Climate and environmental triggers of acute myocardial infarction.
    Eur Heart J. 2023 Feb 25:ehad105. doi: 10.1093.
    PubMed    


  263. THOMAS PE, Vedel-Krogh S, Kamstrup PR, Nordestgaard BG, et al
    Lipoprotein(a) is linked to atherothrombosis and aortic valve stenosis independent of C-reactive protein.
    Eur Heart J. 2023 Feb 21:ehad055. doi: 10.1093.
    PubMed     Abstract available


  264. DIBBEN GO, Faulkner J, Oldridge N, Rees K, et al
    Exercise-based cardiac rehabilitation for coronary heart disease: a meta-analysis.
    Eur Heart J. 2023;44:452-469.
    PubMed     Abstract available


  265. CREA F
    Optimal management of myocardial infarction: from invasive treatment to secondary prevention and rehabilitation.
    Eur Heart J. 2023;44:431-434.
    PubMed    


  266. GRACE SL
    Evidence is indisputable that cardiac rehabilitation provides health benefits and event reduction: time for policy action.
    Eur Heart J. 2023;44:470-472.
    PubMed    


  267. MEHTA SR, McGrath BP
    Anatomy vs. physiology: how should we achieve complete revascularization in acute coronary syndromes?
    Eur Heart J. 2023;44:485-487.
    PubMed    


  268. PRICE S, Kaski JC, Al-Lamee R, Boden WE, et al
    The year in cardiovascular medicine 2022: the top 10 papers in acute cardiac care and ischaemic heart disease.
    Eur Heart J. 2023;44:445-447.
    PubMed    


  269. MORROW DA
    Prognostic interpretation of serial high-sensitivity cardiac troponin in patients presenting with suspected acute coronary syndrome.
    Eur Heart J. 2023;44:513-515.
    PubMed    


  270. PAREEK M, Kragholm KH, Kristensen AMD, Vaduganathan M, et al
    Serial troponin-T and long-term outcomes in suspected acute coronary syndrome.
    Eur Heart J. 2023;44:502-512.
    PubMed     Abstract available


  271. YAMAMOTO H, Fujii M, Takaya T
    High-risk calcified plaque preoperatively detected by non-contrast T1-weighted magnetic resonance imaging and electrocardiogram-gated computed tomography.
    Eur Heart J. 2023;44:534.
    PubMed    


  272. OZKAN J
    Small country big difference: how one physician's vision became a reality and transformed acute myocardial infarction management in the Republic of Mauritius.
    Eur Heart J. 2023 Feb 3:ehad012. doi: 10.1093.
    PubMed    


  273. THYGESEN K, Jaffe AS
    Potential risks of non-cardiac peri-operative myocardial infarction/injury.
    Eur Heart J. 2023 Feb 1:ehac768. doi: 10.1093.
    PubMed    


  274. GERSH BJ, De Mets D
    Revascularization in ischaemic cardiomyopathy: how to interpret current evidence.
    Eur Heart J. 2023;44:365-367.
    PubMed    


  275. VERGALLO R, Volpe M
    A gender issue in the diagnostic imaging work-up of stable coronary artery disease? Insights from DISCHARGE.
    Eur Heart J. 2023;44:340-341.
    PubMed    


    January 2023
  276. PUELACHER C, Gualandro DM, Glarner N, Lurati Buse G, et al
    Long-term outcomes of perioperative myocardial infarction/injury after non-cardiac surgery.
    Eur Heart J. 2023 Jan 27:ehac798. doi: 10.1093.
    PubMed     Abstract available


  277. CREA F
    Ischaemic heart disease: antithrombotic treatment and new therapeutic targets.
    Eur Heart J. 2023;44:239-242.
    PubMed    


  278. KATO ET, Morrow DA, Guo J, Berg DD, et al
    Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis.
    Eur Heart J. 2023;44:293-300.
    PubMed     Abstract available


  279. GALLI M, Ortega-Paz L, Angiolillo DJ
    Oral P2Y12 inhibiting therapy in patients with acute coronary syndrome: finding the sweet spot.
    Eur Heart J. 2023;44:236.
    PubMed    


  280. XIE C, Zhang Y, Lin J
    Are there other factors that influence the assessment of bleeding risk comparing potent P2Y12 inhibitors with clopidogrel?
    Eur Heart J. 2023;44:235.
    PubMed    


  281. CREA F
    Hot topics in ischaemic heart disease: polygenic risk scores, coronary microvascular dysfunction, myocardial injury, and diagnostic role of imaging.
    Eur Heart J. 2023;44:73-76.
    PubMed    


  282. NEGLIA D, Liga R, Gimelli A, Podlesnikar T, et al
    Use of cardiac imaging in chronic coronary syndromes: the EURECA Imaging registry.
    Eur Heart J. 2023;44:142-158.
    PubMed     Abstract available


  283. PEPINE CJ, Bairey Merz CN
    Heart and brain interactions: is small vessel disease a link?
    Eur Heart J. 2023;44:126-128.
    PubMed    


  284. MEJIA-RENTERIA H, Travieso A, Matias-Guiu JA, Yus M, et al
    Coronary microvascular dysfunction is associated with impaired cognitive function: the Cerebral-Coronary Connection study (C3 study).
    Eur Heart J. 2023;44:113-125.
    PubMed     Abstract available


  285. RAY KK, Raal FJ, Kallend DG, Jaros MJ, et al
    Inclisiran and cardiovascular events: a patient-level analysis of phase III trials.
    Eur Heart J. 2023;44:129-138.
    PubMed     Abstract available


  286. OMRAN H
    Troponin for risk stratification after CABG: just one piece of the puzzle.
    Eur Heart J. 2023;44:163-164.
    PubMed    


  287. CHEN T, Zhou H, Guo J, Chen Y, et al
    Intravascular ultrasound and ultrasonic flow ratio-guided zero-contrast rotational atherectomy for calcified coronary lesions.
    Eur Heart J. 2023;44:166.
    PubMed    


    December 2022
  288. TARDIF JC, Pfeffer MA, Dube MP
    Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome.
    Eur Heart J. 2022;43:5062-5063.
    PubMed    


  289. SNIDERMAN AD
    dal-GenE was negative-not positive except for COVID-19.
    Eur Heart J. 2022;43:5061.
    PubMed    


  290. FUKAMACHI D, Okumura Y
    Growing giant coronary artery aneurysm.
    Eur Heart J. 2022;43:5065.
    PubMed    


  291. HUBER K
    Platelet antiaggregation after an acute coronary syndrome: what about the elderly?
    Eur Heart J. 2022;43:5045-5046.
    PubMed    


  292. GIBLETT JP, Matetic A, Jenkins D, Ng CY, et al
    Post-infarction ventricular septal defect: percutaneous or surgical management in the UK national registry.
    Eur Heart J. 2022;43:5020-5032.
    PubMed     Abstract available


  293. ALFONSO F, Aguilar R, Reyes G
    Management of post-infarction ventricular septal defects: are we moving forward?
    Eur Heart J. 2022;43:5033-5036.
    PubMed    


  294. LEE JM, Kim HK, Park KH, Choo EH, et al
    Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial.
    Eur Heart J. 2022 Dec 20:ehac763. doi: 10.1093.
    PubMed     Abstract available


  295. DANCHIN N
    Improved long-term survival after acute myocardial infarction: the success of comprehensive care from the acute stage to the long term.
    Eur Heart J. 2022 Dec 20:ehac714. doi: 10.1093.
    PubMed    


  296. DAVIDSON JA, Banerjee A, Douglas I, Leyrat C, et al
    Primary prevention of acute cardiovascular events by influenza vaccination: an observational study.
    Eur Heart J. 2022 Dec 20:ehac737. doi: 10.1093.
    PubMed     Abstract available


  297. COUGHLAN JJ, Ibanez B
    Reperfusion in ST-elevation myocardial infarction: delays have dangerous ends.
    Eur Heart J. 2022 Dec 14:ehac723. doi: 10.1093.
    PubMed    


  298. HOLMSTROM L, Juntunen S, Vahatalo J, Pakanen L, et al
    Plaque histology and myocardial disease in sudden coronary death: the Fingesture study.
    Eur Heart J. 2022;43:4923-4930.
    PubMed     Abstract available


  299. NISHIHIRA K, Shibata Y, Asada Y
    Intraplaque haemorrhage in rapidly progressing coronary atheroma: insights from histopathological analysis of atherectomy specimens.
    Eur Heart J. 2022;43:4964.
    PubMed    


  300. VERGALLO R, Patrono C
    A BRIGHT outlook for bivalirudin in patients with ST-segment elevation myocardial infarction.
    Eur Heart J. 2022 Dec 7:ehac732. doi: 10.1093.
    PubMed    


  301. O'SULLIVAN JW, Ashley EA, Elliott PM
    Polygenic risk scores for the prediction of cardiometabolic disease.
    Eur Heart J. 2022 Dec 7:ehac648. doi: 10.1093.
    PubMed     Abstract available


  302. EL-CHOULI M, Meddis A, Christensen DM, Gerds TA, et al
    Lifetime risk of comorbidity in patients with simple congenital heart disease: a Danish nationwide study.
    Eur Heart J. 2022 Dec 7:ehac727. doi: 10.1093.
    PubMed     Abstract available


  303. COSTA F, Montalto C, Branca M, Hong SJ, et al
    Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials.
    Eur Heart J. 2022 Dec 7:ehac706. doi: 10.1093.
    PubMed     Abstract available


  304. LIBERALE L, Puspitasari YM, Ministrini S, Akhmedov A, et al
    JCAD promotes arterial thrombosis through PI3K/Akt modulation: a translational study.
    Eur Heart J. 2022 Dec 5:ehac641. doi: 10.1093.
    PubMed     Abstract available


  305. JAMAL J, Idris H, Faour A, Yang W, et al
    Late outcomes of ST-elevation myocardial infarction treated by pharmaco-invasive or primary percutaneous coronary intervention.
    Eur Heart J. 2022 Dec 2:ehac661. doi: 10.1093.
    PubMed     Abstract available


  306. HAN Y
    Chinese guidelines for percutaneous coronary intervention in patients with left main bifurcation disease.
    Eur Heart J. 2022 Dec 2:ehac625. doi: 10.1093.
    PubMed    


  307. PEDICINO D, Liuzzo G
    Mind the map: a multi-omic approach to post-ischaemic cardiac remodelling paves the way for future cardiovascular research.
    Eur Heart J. 2022;43:4677-4678.
    PubMed    


  308. LECOEUR E, Domenge O, Fayol A, Jannot AS, et al
    Epidemiology of heart failure in young adults: a French nationwide cohort study.
    Eur Heart J. 2022 Dec 1:ehac651. doi: 10.1093.
    PubMed     Abstract available


    November 2022
  309. CHRISTENSEN DM, Schjerning AM, Smedegaard L, Charlot MG, et al
    Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction: a Danish nationwide study.
    Eur Heart J. 2022 Nov 26:ehac667. doi: 10.1093.
    PubMed     Abstract available


  310. HAXHA S, Halili A, Malmborg M, Pedersen-Bjergaard U, et al
    Type 2 diabetes mellitus and higher rate of complete atrioventricular block: a Danish Nationwide Registry.
    Eur Heart J. 2022 Nov 26:ehac662. doi: 10.1093.
    PubMed     Abstract available


  311. CREA F
    Controversies in cardiac surgery: left main coronary disease, arterial myocardial revascularization, and prosthetic valves in dialysis.
    Eur Heart J. 2022;43:4603-4605.
    PubMed    


  312. KITE TA, Bountziouka V, Ladwiniec A
    Timing of invasive strategy in non-ST-elevation acute coronary syndrome: risk and reward?
    Eur Heart J. 2022;43:4661.
    PubMed    


  313. ALADIN AI, Zhang C, Waksman R
    Timing of early invasive strategy in patients with non-ST-elevation acute coronary syndrome.
    Eur Heart J. 2022;43:4660.
    PubMed    


  314. GONG X, Shen J, Liu L, Xiao Z, et al
    Pulmonary trunk compression due to multiple aneurysms associated with a coronary-pulmonary artery fistula.
    Eur Heart J. 2022;43:4662.
    PubMed    


  315. TAGGART DP, Audisio K, Gerry S, Robinson NB, et al
    Single versus multiple arterial grafting in diabetic patients at 10 years: the Arterial Revascularization Trial.
    Eur Heart J. 2022;43:4644-4652.
    PubMed     Abstract available


  316. HOLMSTROM L, Chugh SS
    How to minimize in-hospital mortality from acute myocardial infarction: focus on primary prevention of ventricular fibrillation.
    Eur Heart J. 2022 Nov 15. pii: 6827956. doi: 10.1093.
    PubMed    


  317. VAN DEN BROEK WWA, Ten Berg JM
    Is a genotype-guided therapy the optimal strategy to personalize anti-thrombotic management in patients with acute coronary syndrome?
    Eur Heart J. 2022;43:4599-4600.
    PubMed    


  318. BONACA MP, Im K, Magnani G, Bansilal S, et al
    Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54.
    Eur Heart J. 2022 Nov 11. pii: 6823782. doi: 10.1093.
    PubMed     Abstract available


  319. PATHAK S, Lai FY, Miksza J, Petrie MC, et al
    Surgical or Percutaneous Coronary Revascularisation for Heart Failure: An In Silico Model using Routinely Collected Health Data to Emulate a Clinical Trial.
    Eur Heart J. 2022 Nov 9. pii: 6815617. doi: 10.1093.
    PubMed     Abstract available


  320. HEUTS S, Gollmann-Tepekoylu C, Denessen EJS, Olsthoorn JR, et al
    Cardiac troponin release following coronary artery bypass grafting: mechanisms and clinical implications.
    Eur Heart J. 2022 Nov 7. pii: 6807330. doi: 10.1093.
    PubMed     Abstract available


  321. FONSECA HAR, Furtado RHM, Zimerman A, Lemos PA, et al
    Influenza vaccination strategy in acute coronary syndromes: the VIP-ACS trial.
    Eur Heart J. 2022;43:4378-4388.
    PubMed     Abstract available


  322. VARDENY O
    Influenza vaccine in cardiovascular disease: time to move the needle.
    Eur Heart J. 2022;43:4389-4391.
    PubMed    


    October 2022
  323. GARCIA R, Marijon E, Karam N, Narayanan K, et al
    Ventricular fibrillation in acute myocardial infarction: 20-year trends in the FAST-MI study.
    Eur Heart J. 2022 Oct 28. pii: 6776117. doi: 10.1093.
    PubMed     Abstract available


  324. HEYNE S, Macherey S, Meertens MM, Braumann S, et al
    Coronary angiography after cardiac arrest without ST-elevation myocardial infarction: a network meta-analysis.
    Eur Heart J. 2022 Oct 27. pii: 6775293. doi: 10.1093.
    PubMed     Abstract available


  325. VERGALLO R, Volpe M
    Fractional flow reserve or intravascular ultrasound for guiding percutaneous coronary intervention of intermediate coronary stenoses? Sometimes apples and oranges have the same FLAVOUR.
    Eur Heart J. 2022 Oct 26. pii: 6774407. doi: 10.1093.
    PubMed    


  326. XIAO Q, Pu X, Wei X, Chen M, et al
    Refractory cardiogenic shock in a senile atrial fibrillation patient after left atrial appendage occlusion.
    Eur Heart J. 2022 Oct 17. pii: 6761762. doi: 10.1093.
    PubMed    


  327. TYBJAERG-HANSEN A, Nordestgaard LT, Christoffersen M
    Pharmacogenetics-guided CETP inhibition: an open question?
    Eur Heart J. 2022;43:3957-3959.
    PubMed    


  328. TARDIF JC, Pfeffer MA, Kouz S, Koenig W, et al
    Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial.
    Eur Heart J. 2022;43:3947-3956.
    PubMed     Abstract available


  329. VERGALLO R, Liuzzo G
    The REVIVED-BCIS2 trial: percutaneous coronary intervention vs. optimal medical therapy for stable patients with severe ischaemic cardiomyopathy.
    Eur Heart J. 2022 Oct 10. pii: 6754626. doi: 10.1093.
    PubMed    


  330. VERGALLO R, Liuzzo G
    Coronary artery calcium scoring for cardiovascular risk stratification: more pitfalls than advantages?
    Eur Heart J. 2022;43:3510-3511.
    PubMed    


  331. GOTO S, Goto S
    Potent antithrombotic treatments in Asian vs. non-Asian patients.
    Eur Heart J. 2022;43:3553-3555.
    PubMed    


  332. HORI M, Zhu J, Liang Y, Bhatt DL, et al
    Rivaroxaban and aspirin vs. aspirin alone in Asian compared with non-Asian patients with chronic coronary artery disease or peripheral arterial disease: the COMPASS trial.
    Eur Heart J. 2022;43:3542-3552.
    PubMed     Abstract available


    September 2022
  333. ARMSTRONG PW, Bates ER, Gaudino M
    Left main coronary disease: evolving management concepts.
    Eur Heart J. 2022 Sep 29. pii: 6731216. doi: 10.1093.
    PubMed     Abstract available


  334. HESS CN, Bonaca MP
    Risk of remnants and remnant risk in peripheral artery disease.
    Eur Heart J. 2022;43:3270-3272.
    PubMed    


  335. MARQUINA C, Lacaze P, Tiller J, Riaz M, et al
    Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysis.
    Eur Heart J. 2022;43:3243-3254.
    PubMed     Abstract available


  336. VERGALLO R, Pedicino D
    Which mechanical circulatory support device in acute myocardial infarction complicated by cardiogenic shock?
    Eur Heart J. 2022 Sep 6. pii: 6692466. doi: 10.1093.
    PubMed    


  337. CREA F
    Non-invasive diagnosis, antithrombotic treatment, and invasive management of ischaemic heart disease.
    Eur Heart J. 2022;43:3087-3091.
    PubMed    


  338. NADARAJAH R, Wu J, Hurdus B, Asma S, et al
    The collateral damage of COVID-19 to cardiovascular services: a meta-analysis.
    Eur Heart J. 2022;43:3164-3178.
    PubMed     Abstract available


  339. SPIRITO A, Cao D, Mehran R
    Subjective angina or myocardial ischaemia to justify PCI? Never mistake the finger for the moon.
    Eur Heart J. 2022;43:3145-3147.
    PubMed    


  340. LANCELLOTTI P, Go YY, Nchimi A
    Stress imaging versus fractional flow reserve: what comes first-the chicken or the egg?
    Eur Heart J. 2022;43:3129-3131.
    PubMed    


  341. DRIESSEN RS, van Diemen PA, Raijmakers PG, Knuuti J, et al
    Functional stress imaging to predict abnormal coronary fractional flow reserve: the PACIFIC 2 study.
    Eur Heart J. 2022;43:3118-3128.
    PubMed     Abstract available


  342. KITE TA, Kurmani SA, Bountziouka V, Cooper NJ, et al
    Timing of invasive strategy in non-ST-elevation acute coronary syndrome: a meta-analysis of randomized controlled trials.
    Eur Heart J. 2022;43:3148-3161.
    PubMed     Abstract available


  343. GUEDENEY P, Thiele H, Collet JP
    Timing of invasive management of NSTE-ACS: is the time up for early management?
    Eur Heart J. 2022;43:3161-3163.
    PubMed    


    August 2022
  344. VON LEWINSKI D, Kolesnik E, Tripolt NJ, Pferschy PN, et al
    Empagliflozin in acute Myocardial Infarction: the EMMY trial.
    Eur Heart J. 2022 Aug 29. pii: 6677315. doi: 10.1093.
    PubMed     Abstract available


  345. HARRINGTON J, Anker S, Butler J
    Putting the Puzzle Together: SGLT2 Inhibitors from Prevention to Treatment of Heart Failure.
    Eur Heart J. 2022 Aug 29. pii: 6677316. doi: 10.1093.
    PubMed    


  346. GIDDING SS, Colangelo LA, Nwabuo CC, Lewis CE, et al
    PDAY risk score predicts cardiovascular events in young adults: the CARDIA study.
    Eur Heart J. 2022;43:2892-2900.
    PubMed     Abstract available


    July 2022
  347. DOLEJSI T, Delgobo M, Schuetz T, Tortola L, et al
    Adult T-cells impair neonatal cardiac regeneration.
    Eur Heart J. 2022;43:2698-2709.
    PubMed     Abstract available



  348. Corrigendum to: Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registry.
    Eur Heart J. 2022 Jul 6. pii: 6632321. doi: 10.1093.
    PubMed    


  349. GAUDINO M, Farkouh ME, Stone GW
    Left main revascularization: an evidence-based reconciliation.
    Eur Heart J. 2022;43:2421-2424.
    PubMed    


  350. FISCHER J, Godecke A, Kelm M, Heusch G, et al
    Master switches in cardiac ischaemia: the Collaborative Research Center (CRC) 1116 of the German Research Foundation.
    Eur Heart J. 2022;43:2350-2351.
    PubMed    


    June 2022
  351. CREA F
    Antiplatelet treatment of acute coronary syndromes: novel clinical and translational perspectives.
    Eur Heart J. 2022;43:2253-2256.
    PubMed    


  352. ZHU H, Chen T, Huang J
    An attempt to better show some results such as the comparison of mortality and major adverse cardiovascular events between the abnormal and normal coronary flow reserve cohorts.
    Eur Heart J. 2022;43:2338-2339.
    PubMed    


  353. SCHIELE F, Meneveau N
    NSTEMI management: a fall from GRACE?
    Eur Heart J. 2022;43:2300-2302.
    PubMed    


  354. TAKEI Y, Abe N, Bohgaki M, Kasahara H, et al
    Paradoxical enlargement of immunoglobulin G4 (IgG4)-related coronary aneurysms despite controlling serum IgG4 level.
    Eur Heart J. 2022;43:2250.
    PubMed    


  355. CACHEUX M, Akar FG
    A novel exosome-based therapy for post-MI arrhythmias.
    Eur Heart J. 2022;43:2157-2159.
    PubMed    


    May 2022
  356. GANESANANTHAN S, Rajkumar CA, Foley M, Thompson D, et al
    Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial.
    Eur Heart J. 2022 May 26. pii: 6593472. doi: 10.1093.
    PubMed     Abstract available


  357. VAN VELDHUISEN SL, Gorter TM, van Woerden G, de Boer RA, et al
    Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis.
    Eur Heart J. 2022;43:1955-1969.
    PubMed     Abstract available


  358. VALGIMIGLI M, Smits PC, Frigoli E, Bongiovanni D, et al
    Duration of Antiplatelet Therapy After Complex Percutaneous Coronary Intervention In Patients at High Bleeding Risk: a MASTER DAPT trial sub-analysis.
    Eur Heart J. 2022 May 17. pii: 6587125. doi: 10.1093.
    PubMed     Abstract available


  359. SPOSITO AC
    Soluble LOX-1 levels during acute coronary syndrome: a potent and multifaceted warning sign for cardiovascular risk.
    Eur Heart J. 2022;43:1861-1863.
    PubMed    


  360. KRALER S, Wenzl FA, Georgiopoulos G, Obeid S, et al
    Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes.
    Eur Heart J. 2022;43:1849-1860.
    PubMed     Abstract available


  361. WANG J, Chen H, Zhang L
    Coronary artery fistula bypassed the left main coronary artery blocked by a large cardiogenic thrombus.
    Eur Heart J. 2022;43:1885.
    PubMed    


  362. LU X, Liu Z, Cui Q, Liu F, et al
    A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study.
    Eur Heart J. 2022;43:1702-1711.
    PubMed     Abstract available


  363. HAGEMAN SHJ, McKay AJ, Ueda P, Gunn LH, et al
    Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm.
    Eur Heart J. 2022;43:1715-1727.
    PubMed     Abstract available


  364. FRANTZ S, Hundertmark MJ, Schulz-Menger J, Bengel FM, et al
    Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies.
    Eur Heart J. 2022 May 4. pii: 6578707. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  365. CREA F
    Inflammation, targeted proteomics, and microvascular dysfunction: the new frontiers of ischaemic heart disease.
    Eur Heart J. 2022;43:1517-1520.
    PubMed    


  366. STEFFENS S, Nahrendorf M, Madonna R
    Immune cells in cardiac homeostasis and disease: emerging insights from novel technologies.
    Eur Heart J. 2022;43:1533-1541.
    PubMed     Abstract available


  367. KELSHIKER MA, Seligman H, Howard JP, Rahman H, et al
    Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis.
    Eur Heart J. 2022;43:1582-1593.
    PubMed     Abstract available


  368. MORICI N, De Servi S, De Luca L, Crimi G, et al
    Management of acute coronary syndromes in older adults.
    Eur Heart J. 2022;43:1542-1553.
    PubMed     Abstract available


  369. KELSHIKER MA, Seligman H, Howard JP, Rahman H, et al
    Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis.
    Eur Heart J. 2022;43:1582-1593.
    PubMed     Abstract available


  370. HONG S, Kim KS, Han K, Park CY, et al
    Acromegaly and cardiovascular outcomes: a cohort study.
    Eur Heart J. 2022;43:1491-1499.
    PubMed     Abstract available


  371. FERNANDEZ ASENSIO R, Pascual Calleja I, Moris de la Tassa C, Colunga Blanco S, et al
    Pneumopericardium mimicking ST-segment elevation acute coronary syndrome.
    Eur Heart J. 2022;43:1516.
    PubMed    


  372. SAMMONS E, Hopewell JC, Chen F, Stevens W, et al
    Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.
    Eur Heart J. 2022;43:1416-1424.
    PubMed     Abstract available


  373. BATRA G, Aktaa S, Wallentin L, Maggioni AP, et al
    Data standards for acute coronary syndrome and percutaneous coronary intervention: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart).
    Eur Heart J. 2022 Apr 5. pii: 6563567. doi: 10.1093.
    PubMed     Abstract available


    March 2022
  374. BUCCIARELLI-DUCCI C, Ajmone-Marsan N, Di Carli M, Nicol E, et al
    The year in cardiovascular medicine 2021: imaging.
    Eur Heart J. 2022;43:1288-1295.
    PubMed     Abstract available


  375. BYRNE RA, Rai H, Colleran R
    Amphilimus-eluting stents in coronary artery disease: finally, a sweet spot for patients with diabetes mellitus?
    Eur Heart J. 2022;43:1331-1333.
    PubMed    


  376. HAN Y
    Chinese expert consensus statement on dual antiplatelet therapy in patients with coronary artery disease.
    Eur Heart J. 2022;43:1283-1285.
    PubMed    


  377. ROMAGUERA R, Salinas P, Gomez-Lara J, Brugaletta S, et al
    Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial.
    Eur Heart J. 2022;43:1320-1330.
    PubMed     Abstract available


  378. OKA S, Endo H, Takagi K, Yamagata K, et al
    Mechanical coronary artery stenosis induced by active fixation left ventricular lead: a case of acute complication after cardiac resynchronization therapy device implantation.
    Eur Heart J. 2022;43:1271.
    PubMed    


  379. THYGESEN K, Jaffe AS
    Revisiting the definition of perioperative myocardial infarction after coronary artery bypass grafting.
    Eur Heart J. 2022 Mar 17. pii: 6549761. doi: 10.1093.
    PubMed    


  380. HAN Y, Li Y
    Adherence to P2Y12 inhibitors in acute coronary syndrome after a percutaneous coronary intervention: what can we improve?
    Eur Heart J. 2022 Mar 17. pii: 6549760. doi: 10.1093.
    PubMed    


  381. TURGEON RD, Koshman SL, Dong Y, Graham MM, et al
    P2Y12 inhibitor adherence trajectories in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prognostic implications.
    Eur Heart J. 2022 Mar 17. pii: 6549798. doi: 10.1093.
    PubMed     Abstract available


  382. TUAL-CHALOT S, Stellos K
    Chrono-pharmacology-based antiplatelet therapy for acute myocardial infarction.
    Eur Heart J. 2022 Mar 10. pii: 6546087. doi: 10.1093.
    PubMed    


  383. DAWKINS JF, Ehdaie A, Rogers R, Soetkamp D, et al
    Biological substrate modification suppresses ventricular arrhythmias in a porcine model of chronic ischaemic cardiomyopathy.
    Eur Heart J. 2022 Mar 9. pii: 6545456. doi: 10.1093.
    PubMed     Abstract available


  384. TAN S, White HD, Layland J
    Heparin use in acute coronary syndromes and cardiovascular interventions: habit or evidence based?
    Eur Heart J. 2022;43:1008-1011.
    PubMed    


  385. SILVAIN J, Hausenloy D, Zeitouni M
    Appropriate criteria for the definition of Type 4a MI.
    Eur Heart J. 2022;43:1013-1014.
    PubMed    


    February 2022
  386. MOLEDINA SM, Kontopantelis E, Wijeysundera HC, Banerjee S, et al
    Ethnicity-dependent performance of the Global Registry of Acute Coronary Events risk score for prediction of non-ST-segment elevation myocardial infarction in-hospital mortality: nationwide cohort study.
    Eur Heart J. 2022 Feb 24. pii: 6529720. doi: 10.1093.
    PubMed     Abstract available


  387. ZENG C, Rosenberg L, Li X, Djousse L, et al
    Sodium-containing acetaminophen and cardiovascular outcomes in individuals with and without hypertension.
    Eur Heart J. 2022 Feb 24. pii: 6535634. doi: 10.1093.
    PubMed     Abstract available


  388. PRICE S, Katz J, Kaufmann CC, Huber K, et al
    The year in cardiovascular medicine 2021: acute cardiovascular care and ischaemic heart disease.
    Eur Heart J. 2022;43:800-806.
    PubMed    


  389. SHRAUNER W, Lord EM, Nguyen XT, Song RJ, et al
    Frailty and cardiovascular mortality in more than 3 million US Veterans.
    Eur Heart J. 2022;43:818-826.
    PubMed     Abstract available


  390. VAROTTO L, De Boni A, Iannucci G, Caprioglio F, et al
    Uncommon intravascular lithotripsy for the treatment of subclavian steal syndrome: a case presenting with concomitant acute coronary syndrome and transient ischaemic attack.
    Eur Heart J. 2022;43:840.
    PubMed    


  391. LIUZZO G, Volpe M
    Percutaneous coronary intervention vs. coronary artery bypass graft for left main coronary artery disease: a never-ending debate.
    Eur Heart J. 2022 Feb 21. pii: 6533241. doi: 10.1093.
    PubMed    


  392. OMRAN H, Deutsch MA, Groezinger E, Zittermann A, et al
    High-sensitivity cardiac troponin I after coronary artery bypass grafting for post-operative decision-making.
    Eur Heart J. 2022 Feb 15. pii: 6528587. doi: 10.1093.
    PubMed     Abstract available


  393. LIUZZO G, Volpe M
    PARADISE-MI suggests a limited role of intensified neuro-hormonal inhibition in the management of acute myocardial infarction with reduced ejection fraction.
    Eur Heart J. 2022;43:559-560.
    PubMed    


  394. POLZL L, Thielmann M, Cymorek S, Nagele F, et al
    Impact of myocardial injury after coronary artery bypass grafting on long-term prognosis.
    Eur Heart J. 2022 Feb 9. pii: 6525341. doi: 10.1093.
    PubMed     Abstract available


  395. DE CATERINA R, Liga R, Boden WE
    Myocardial revascularization in ischaemic cardiomyopathy: routine practice vs. scientific evidence.
    Eur Heart J. 2022;43:387-390.
    PubMed    


    January 2022
  396. BRAUNWALD E
    How to live to 100 before developing clinical coronary artery disease: a suggestion.
    Eur Heart J. 2022;43:249-250.
    PubMed    


  397. SLIWICKA O, Damman P, Habets J
    Stress dynamic CT perfusion in the evaluation of acute coronary syndrome.
    Eur Heart J. 2022;43:244.
    PubMed    


  398. CREA F
    Hot topics in ischaemic heart disease: revascularization, hibernation, type 2 infarction, and proteomics.
    Eur Heart J. 2022;43:89-92.
    PubMed    


  399. NEWBY LK
    A new biomarker of acute coronary ischaemia: from bench to bedside?
    Eur Heart J. 2022;43:164-166.
    PubMed    


  400. RYAN M, Morgan H, Chiribiri A, Nagel E, et al
    Myocardial viability testing: all STICHed up, or about to be REVIVED?
    Eur Heart J. 2022;43:118-126.
    PubMed     Abstract available


  401. CUBEDO J, Padro T, Vilahur G, Crea F, et al
    Glycosylated apolipoprotein J in cardiac ischaemia: molecular processing and circulating levels in patients with acute ischaemic events.
    Eur Heart J. 2022;43:153-163.
    PubMed     Abstract available


  402. QUADRI G, Tomassini F, Cerrato E, Varbella F, et al
    Emergency treatment of a giant coronary aneurysm: percutaneous intervention with coronary and peripheral tools.
    Eur Heart J. 2022;43:168.
    PubMed    


  403. DEMIR OM, Rahman H, van de Hoef TP, Escaned J, et al
    Invasive and non-invasive assessment of ischaemia in chronic coronary syndromes: translating pathophysiology to clinical practice.
    Eur Heart J. 2022;43:105-117.
    PubMed     Abstract available


    December 2021
  404. WANG R, Serruys PW, Gao C, Hara H, et al
    Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease.
    Eur Heart J. 2021;43:56-67.
    PubMed     Abstract available


  405. NICOLAS J, Giustino G, Dangas G
    Periprocedural myocardial infarction: multiple definitions and still a quest for consensus.
    Eur Heart J. 2021 Dec 21. pii: 6471447. doi: 10.1093.
    PubMed    


  406. LOZANO I, Vegas JM, Rondan J
    Percutaneous intervention in patients with cancer: can we offer an improvement in safety?
    Eur Heart J. 2021;42:4981.
    PubMed    


  407. WHITE HD, Schwartz GG, Szarek M, Bhatt DL, et al
    Alirocumab after acute coronary syndrome in patients with a history of heart failure.
    Eur Heart J. 2021 Dec 18. pii: 6469637. doi: 10.1093.
    PubMed     Abstract available


  408. GALLI M, Benenati S, Franchi F, Rollini F, et al
    Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials.
    Eur Heart J. 2021 Dec 16. pii: 6464193. doi: 10.1093.
    PubMed     Abstract available


  409. CREA F
    Percutaneous coronary interventions: more complex than fixing stenoses.
    Eur Heart J. 2021;42:4607-4611.
    PubMed    


  410. WHITE HD
    Cardiac death should be the primary endpoint for revascularization trials and meta-analyses.
    Eur Heart J. 2021;42:4697-4698.
    PubMed    


  411. AL-LAMEE R, Mintz GS
    What are the PROSPECTs and clinical implications of vulnerable plaque?
    Eur Heart J. 2021;42:4680-4682.
    PubMed    


  412. KEDHI E, Berta B, Roleder T, Hermanides RS, et al
    Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial.
    Eur Heart J. 2021;42:4671-4679.
    PubMed     Abstract available


  413. AL-LAMEE R, Mintz GS
    What are the PROSPECTs and clinical implications of vulnerable plaque?
    Eur Heart J. 2021;42:4680-4682.
    PubMed    


    November 2021
  414. EGGERS KM, James SK, Lindahl B
    Myocardial infarction after elective percutaneous coronary intervention-which cardiac troponin cut-off to use?
    Eur Heart J. 2021 Nov 24. pii: 6438090. doi: 10.1093.
    PubMed    


  415. BOR WL, Ten Berg JM
    Known or new atrial fibrillation in patients with acute coronary syndrome: what's the difference?
    Eur Heart J. 2021;42:4562-4564.
    PubMed    


  416. DE SILVA R, Cheng K
    Microvascular angina: quo tendimus?
    Eur Heart J. 2021;42:4601-4604.
    PubMed    


  417. SHIMOKAWA H, Suda A, Takahashi J, Berry C, et al
    Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group.
    Eur Heart J. 2021;42:4592-4600.
    PubMed     Abstract available


  418. PITT B, Ferreira JP, Zannad F
    Why are mineralocorticoid receptor antagonists the Cinderella in evidence-based treatment of myocardial infarction complicated with heart failure? Lessons from PARADISE-MI.
    Eur Heart J. 2021 Nov 12. pii: 6425576. doi: 10.1093.
    PubMed    


  419. CHIKWE J, Alfieri OR
    The optimal strategy for multivessel coronary revascularization.
    Eur Heart J. 2021 Nov 11. pii: 6425621. doi: 10.1093.
    PubMed    


  420. WINTHER S, Schmidt SE, Knuuti J, Bottcher M, et al
    Selecting the right cohorts and endpoints for the validation of pre-test probability models for obstructive coronary artery disease.
    Eur Heart J. 2021;42:4402-4403.
    PubMed    


  421. DERIMAY F, Finet G, Rioufol G
    Coronary artery stenosis prediction does not mean coronary artery stenosis obstruction.
    Eur Heart J. 2021;42:4401.
    PubMed    


  422. EGIDY ASSENZA G, Dimopoulos K, Budts W, Donti A, et al
    Management of acute cardiovascular complications in pregnancy.
    Eur Heart J. 2021;42:4224-4240.
    PubMed     Abstract available


    October 2021
  423. BIAN L, Fang Z, Qian H, Wu Z, et al
    Dumbbell on the heart: two giant left coronary artery aneurysms in an adolescent.
    Eur Heart J. 2021;42:4195.
    PubMed    


  424. AHN JM, Zimmermann FM, Arora S, Solberg OG, et al
    Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation.
    Eur Heart J. 2021 Oct 19. pii: 6401958. doi: 10.1093.
    PubMed     Abstract available


  425. TSUDA K, Kanzaki Y, Hoshiga M
    Early cardiac magnetic resonance leads to diagnose the etiology of myocardial infarction with non-obstructive coronary arteries.
    Eur Heart J. 2021 Oct 18. pii: 6400298. doi: 10.1093.
    PubMed    


  426. WADSTROM BN, Wulff AB, Pedersen KM, Jensen GB, et al
    Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study.
    Eur Heart J. 2021 Oct 18. pii: 6399975. doi: 10.1093.
    PubMed     Abstract available


  427. GALLI M, Angiolillo DJ
    Non-opioid analgesics in patients undergoing percutaneous coronary intervention: hype or hope?
    Eur Heart J. 2021;42:4037-4039.
    PubMed    


  428. LECHNER I, Reindl M, Tiller C, Holzknecht M, et al
    Impact of COVID-19 pandemic restrictions on ST-elevation myocardial infarction: a cardiac magnetic resonance imaging study.
    Eur Heart J. 2021 Oct 11. pii: 6386704. doi: 10.1093.
    PubMed     Abstract available


  429. BANNING AP, Serruys P, De Maria GL, Ryan N, et al
    Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study.
    Eur Heart J. 2021 Oct 7. pii: 6383065. doi: 10.1093.
    PubMed     Abstract available


  430. CREA F
    The challenge of risk stratification in suspected angina, in myocardial infarction without risk factors, and in frail patients.
    Eur Heart J. 2021;42:3807-3811.
    PubMed    


  431. CURZEN N, Nicholas Z, Stuart B, Wilding S, et al
    Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial.
    Eur Heart J. 2021;42:3844-3852.
    PubMed     Abstract available


  432. JAFFER FA, Mehilli J, Escaned J
    Left main coronary disease at the bifurcation: should the pendulum swing back towards the provisional stenting approach?
    Eur Heart J. 2021;42:3840-3843.
    PubMed    


  433. SENIOR R, Khattar R
    Stress echocardiography: the quest for risk stratification beyond myocardial ischaemia.
    Eur Heart J. 2021;42:3879-3881.
    PubMed    


  434. AVIS SR, Vernon ST, Hagstrom E, Figtree GA, et al
    Coronary artery disease in the absence of traditional risk factors: a call for action.
    Eur Heart J. 2021;42:3822-3824.
    PubMed    


  435. MENG SW, Ko TY, Hsieh MY
    Simultaneous acute pulmonary and coronary embolism.
    Eur Heart J. 2021;42:3888.
    PubMed    


    September 2021
  436. HAN Y
    Long-term outcomes of new-generation coronary stents in China.
    Eur Heart J. 2021 Sep 18. pii: 6372216. doi: 10.1093.
    PubMed    


  437. SINHA A, Rahman H, Webb A, Shah AM, et al
    Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction.
    Eur Heart J. 2021 Sep 16. pii: 6371296. doi: 10.1093.
    PubMed     Abstract available


  438. PETERS SAE, Kluin J
    Why do women do worse after coronary artery bypass grafting?
    Eur Heart J. 2021 Sep 15. pii: 6370651. doi: 10.1093.
    PubMed    


  439. LOPEZ-SENDON JL, Cyr DD, Mark DB, Bangalore S, et al
    Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial.
    Eur Heart J. 2021 Sep 13. pii: 6368943. doi: 10.1093.
    PubMed     Abstract available


  440. BAYES-GENIS A, Diez J
    Transition to heart failure in hypertension: going to the heart of the matter.
    Eur Heart J. 2021 Sep 13. pii: 6369562. doi: 10.1093.
    PubMed    


  441. BROWN JM, Zhou W, Weber B, Divakaran S, et al
    Low coronary flow relative to myocardial mass predicts heart failure in symptomatic hypertensive patients with no obstructive coronary artery disease.
    Eur Heart J. 2021 Sep 7. pii: 6365821. doi: 10.1093.
    PubMed     Abstract available


  442. PETERSEN JK, Haider Butt J, Yafasova A, Torp-Pedersen C, et al
    Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study.
    Eur Heart J. 2021 Sep 3. pii: 6363625. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  443. CREA F
    Pulmonary embolism, COVID, and bleeding risk in acute coronary syndromes: a Focus Issue on thrombosis and antithrombotic treatment.
    Eur Heart J. 2021;42:3109-3113.
    PubMed    


  444. YANG Q, Sun D, Pei C, Zeng Y, et al
    LDL cholesterol levels and in-hospital bleeding in patients on high-intensity antithrombotic therapy: findings from the CCC-ACS project.
    Eur Heart J. 2021;42:3175-3186.
    PubMed     Abstract available


  445. CERRATO E, Giacobbe F, Quadri G, Macaya F, et al
    Antiplatelet therapy in patients with conservatively managed spontaneous coronary artery dissection from the multicentre DISCO registry.
    Eur Heart J. 2021;42:3161-3171.
    PubMed     Abstract available


  446. LUSEBRINK E, Massberg S, Orban M
    The lack of evidence-based therapeutic strategies for left ventricular unloading during venoarterial extracorporeal membrane oxygenation therapy calls for randomized trials.
    Eur Heart J. 2021;42:3105-3106.
    PubMed    


  447. KLOECKNER M, Guihaire J, Hascoet S
    Congestive pulmonary oedema during venoarterial extracorporeal membrane oxygenation support: a plea for balloon atrial septostomy.
    Eur Heart J. 2021;42:3103-3104.
    PubMed    


  448. DAVIERWALA PM, Gao C, Thuijs DJFM, Wang R, et al
    Single or multiple arterial bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel or left main coronary artery disease.
    Eur Heart J. 2021 Aug 18. pii: 6354120. doi: 10.1093.
    PubMed     Abstract available


  449. GAUDINO M, Di Franco A, Alexander JH, Bakaeen F, et al
    Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data.
    Eur Heart J. 2021 Aug 2. pii: 6333765. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  450. KOSYAKOVSKY LB, Austin PC, Ross HJ, Wang X, et al
    Early invasive coronary angiography and acute ischaemic heart failure outcomes.
    Eur Heart J. 2021 Jul 30. pii: 6331345. doi: 10.1093.
    PubMed     Abstract available


  451. GOROG DA, Navarese EP, Andreotti F
    Should we consider low LDL-cholesterol a marker of in-hospital bleeding in patients with acute coronary syndrome undergoing percutaneous coronary intervention?
    Eur Heart J. 2021 Jul 29. pii: 6330652. doi: 10.1093.
    PubMed    


  452. COLLISON D, Didagelos M, Aetesam-Ur-Rahman M, Copt S, et al
    Post-stenting fractional flow reserve vs coronary angiography for optimisation of percutaneous coronary intervention: TARGET-FFR trial.
    Eur Heart J. 2021 Jul 19. pii: 6323924. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  453. NAVARESE EP, Lansky AJ, Kereiakes DJ, Kubica J, et al
    Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis.
    Eur Heart J. 2021 May 18. pii: 6276780. doi: 10.1093.
    PubMed     Abstract available


  454. HILDICK-SMITH D, Egred M, Banning A, Brunel P, et al
    The European bifurcation club Left Main Coronary Stent study: a randomized comparison of stepwise provisional vs. systematic dual stenting strategies (EBC MAIN).
    Eur Heart J. 2021 May 18. pii: 6276782. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.